| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2024 |
Grass JK, Grupp K, Kluth M, Hube-Magg C, Simon R, Kemper M, Izbicki JR, Sauter G, Melling N. CD10 Expression Correlates with Earlier Tumour Stages and Left-Sided Tumour Location in Colorectal Cancer but Has No Prognostic Impact in a European Cohort. Cancers. 16. PMID 38672555 DOI: 10.3390/cancers16081473 |
0.01 |
|
| 2024 |
Plage H, Furlano K, Hofbauer S, Weinberger S, Ralla B, Franz A, Fendler A, de Martino M, Roßner F, Elezkurtaj S, Kluth M, Lennartz M, Blessin NC, Marx AH, Samtleben H, ... ... Simon R, et al. PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors. Bmc Urology. 24: 96. PMID 38658905 DOI: 10.1186/s12894-024-01482-z |
0.01 |
|
| 2024 |
Lennartz M, Löhr N, Höflmayer D, Dwertmann Rico S, von Bargen C, Kind S, Reiswich V, Viehweger F, Lutz F, Bertram V, Fraune C, Gorbokon N, Weidemann S, Blessin NC, Hube-Magg C, ... ... Simon R, et al. TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor Entities. The American Journal of Surgical Pathology. PMID 38647255 DOI: 10.1097/PAS.0000000000002213 |
0.01 |
|
| 2024 |
Lennartz M, Amezada D, Höflmayer D, Dwertmann Rico S, von Bargen C, Kind S, Reiswich V, Viehweger F, Lutz F, Bertram V, Fraune C, Gorbokon N, Weidemann S, Hube-Magg C, Menz A, ... ... Simon R, et al. Steroidogenic Acute Regulatory Protein Is a Useful Marker for Sex-Cord-Stroma Tumors and Normal and Neoplastic Adrenocortical Tissue. Archives of Pathology & Laboratory Medicine. PMID 38484775 DOI: 10.5858/arpa.2023-0281-OA |
0.01 |
|
| 2024 |
Jacobsen F, Pushpadevan R, Viehweger F, Freytag M, Schlichter R, Gorbokon N, Büscheck F, Luebke AM, Putri D, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Fraune C, Bernreuther C, ... ... Simon R, et al. Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors. Pathology, Research and Practice. 256: 155175. PMID 38452580 DOI: 10.1016/j.prp.2024.155175 |
0.01 |
|
| 2024 |
Debatin NF, Bady E, Mandelkow T, Huang Z, Lurati MCJ, Raedler JB, Müller JH, Vettorazzi E, Plage H, Samtleben H, Klatte T, Hofbauer S, Elezkurtaj S, Furlano K, Weinberger S, ... ... Simon R, et al. Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer. European Urology. PMID 38383257 DOI: 10.1016/j.eururo.2024.01.023 |
0.01 |
|
| 2024 |
Kosinski J, Sechi A, Hain J, Villwock S, Ha SA, Hauschulz M, Rose M, Steib F, Ortiz-Brüchle N, Heij L, Maas SL, van der Vorst EPC, Knoesel T, Altendorf-Hofmann A, Simon R, et al. ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration. Molecular Oncology. PMID 38375974 DOI: 10.1002/1878-0261.13609 |
0.01 |
|
| 2024 |
Müller JH, Plage H, Elezkurtaj S, Mandelkow T, Huang Z, Lurati MCJ, Raedler JB, Debatin NF, Vettorazzi E, Samtleben H, Hofbauer S, Furlano K, Neymeyer J, Goranova I, Ralla B, ... ... Simon R, et al. Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomas. Frontiers in Oncology. 13: 1342367. PMID 38282671 DOI: 10.3389/fonc.2023.1342367 |
0.01 |
|
| 2024 |
Lennartz M, Benjamin Dünnebier N, Höflmayer D, Dwertmann Rico S, Kind S, Reiswich V, Viehweger F, Lutz F, Fraune C, Gorbokon N, Luebke AM, Hube-Magg C, Büscheck F, Menz A, Uhlig R, ... ... Simon R, et al. GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the Pancreas. The American Journal of Surgical Pathology. PMID 38271200 DOI: 10.1097/PAS.0000000000002186 |
0.01 |
|
| 2024 |
Viehweger F, Böcker C, Weidemann S, Freytag M, Menz A, Büscheck F, Luebke AM, Putri D, Kluth M, Hube-Magg C, Hinsch A, Lennartz M, Lutz F, Reiswich V, Höflmayer D, ... ... Simon R, et al. Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities. Diagnostic Pathology. 19: 12. PMID 38218896 DOI: 10.1186/s13000-023-01434-5 |
0.01 |
|
| 2023 |
Mandelkow T, Bady E, Lurati MCJ, Raedler JB, Müller JH, Huang Z, Vettorazzi E, Lennartz M, Clauditz TS, Lebok P, Steinhilper L, Woelber L, Sauter G, Berkes E, Bühler S, ... ... Simon R, et al. Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry. Biomedicines. 11. PMID 38137396 DOI: 10.3390/biomedicines11123175 |
0.01 |
|
| 2023 |
Möller K, Uhlig R, Gorbokon N, Dum D, Menz A, Büscheck F, Luebke AM, Hube-Magg C, Hinsch A, Höflmayer D, Fraune C, Lebok P, Weidemann S, Lennartz M, Jacobsen F, ... ... Simon R, et al. Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors. Molecular and Cellular Endocrinology. 112106. PMID 37951531 DOI: 10.1016/j.mce.2023.112106 |
0.01 |
|
| 2023 |
Schallenberg S, Plage H, Hofbauer S, Furlano K, Weinberger S, Bruch PG, Roßner F, Elezkurtaj S, Kluth M, Lennartz M, Blessin NC, Marx AH, Samtleben H, Fisch M, Rink M, ... ... Simon R, et al. Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors. Acta Oncologica (Stockholm, Sweden). 1-10. PMID 37938166 DOI: 10.1080/0284186X.2023.2277344 |
0.01 |
|
| 2023 |
Tribian LS, Lennartz M, Höflmayer D, de Wispelaere N, Dwertmann Rico S, von Bargen C, Kind S, Reiswich V, Viehweger F, Lutz F, Bertram V, Fraune C, Gorbokon N, Weidemann S, Hube-Magg C, ... ... Simon R, et al. Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues. Diagnostics (Basel, Switzerland). 13. PMID 37892063 DOI: 10.3390/diagnostics13203242 |
0.01 |
|
| 2023 |
Kaczmarek K, Plage H, Furlano K, Hofbauer S, Weinberger S, Ralla B, Franz A, Fendler A, de Martino M, Roßner F, Schallenberg S, Elezkurtaj S, Kluth M, Lennartz M, Blessin NC, ... ... Simon R, et al. Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder. International Urology and Nephrology. PMID 37777995 DOI: 10.1007/s11255-023-03800-0 |
0.01 |
|
| 2023 |
Rasool RU, O'Connor CM, Das CK, Alhusayan M, Verma BK, Islam S, Frohner IE, Deng Q, Mitchell-Velasquez E, Sangodkar J, Ahmed A, Linauer S, Mudrak I, Rainey J, Zawacki KP, ... ... Simon R, et al. Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance. Nature Communications. 14: 5253. PMID 37644036 DOI: 10.1038/s41467-023-40760-6 |
0.01 |
|
| 2023 |
Lennartz M, Csomós H, Chirico V, Weidemann S, Gorbokon N, Menz A, Büscheck F, Hube-Magg C, Höflmayer D, Bernreuther C, Blessin NC, Lebok P, Sauter G, Steurer S, Burandt E, ... ... Simon R, et al. Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid. Scientific Reports. 13: 12917. PMID 37558687 DOI: 10.1038/s41598-023-39945-2 |
0.01 |
|
| 2023 |
Uhlig R, Bröker N, Weidemann S, Gorbokon N, Menz A, Büscheck F, Luebke AM, Putri D, Kluth M, Hube-Magg C, Hinsch A, Lennartz M, Reiswich V, Höflmayer D, Fraune C, ... ... Simon R, et al. CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas. Plos One. 18: e0287528. PMID 37379306 DOI: 10.1371/journal.pone.0287528 |
0.01 |
|
| 2023 |
Sebastian A, Sebastian N, Arulthasan M, Simon R, Nicastro JM. Necrotizing Soft Tissue Infection Secondary to Streptococcus constellatus, Actinomyces odontolyticus, and Gemella morbillorum in an Intravenous Drug User: A Case Report and Literature Review. Cureus. 15: e37314. PMID 37181983 DOI: 10.7759/cureus.37314 |
0.01 |
|
| 2023 |
Yamada Y, Simon R, Iwane K, Nakanishi Y, Takeuchi Y, Yoshizawa A, Takada M, Toi M, Haga H, Marx A, Sauter G. An exploratory study for tuft cells in the breast and their relevance in triple-negative breast cancer: the possible relationship of SOX9. Bmc Cancer. 23: 438. PMID 37179317 DOI: 10.1186/s12885-023-10949-5 |
0.01 |
|
| 2023 |
Dwertmann Rico S, Schliesser SJA, Gorbokon N, Dum D, Menz A, Büscheck F, Hinsch A, Lennartz M, von Bargen C, Bawahab AA, Luebke AM, Hube-Magg C, Fraune C, Lebok P, Clauditz TS, ... ... Simon R, et al. Pattern of MUC6 expression across 119 different tumor types: A tissue microarray study on 15 412 tumors. Pathology International. PMID 37057870 DOI: 10.1111/pin.13322 |
0.01 |
|
| 2023 |
Bruch PG, Plage H, Hofbauer S, Kornienko K, Weinberger S, Roßner F, Schallenberg S, Kluth M, Lennartz M, Blessin NC, Marx AH, Samtleben H, Fisch M, Rink M, Slojewski M, ... ... Simon R, et al. Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder. Experimental and Molecular Pathology. 131: 104860. PMID 36997051 DOI: 10.1016/j.yexmp.2023.104860 |
0.01 |
|
| 2023 |
Gorbokon N, Timm P, Dum D, Menz A, Büscheck F, Völkel C, Hinsch A, Lennartz M, Luebke AM, Hube-Magg C, Fraune C, Krech T, Lebok P, Clauditz TS, Jacobsen F, ... ... Simon R, et al. Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary Gland. Diagnostics (Basel, Switzerland). 13. PMID 36980510 DOI: 10.3390/diagnostics13061202 |
0.01 |
|
| 2023 |
Bady E, Moeller K, Mandelkow T, Raedler JB, Yang C, Ebner J, Lurati MCJ, Simon R, Vettorazzi E, Buescheck F, Luebke AM, Dum D, Menz A, Sauter G, Hoeflmayer D, et al. BLEACH&STAIN 15-marker multiplexed imaging in 3098 human carcinomas reveals 6 major PD-L1-driven immune phenotypes with distinct spatial orchestration. Molecular Cancer Research : McR. PMID 36976297 DOI: 10.1158/1541-7786.MCR-22-0593 |
0.01 |
|
| 2023 |
Yang C, Mandelkow T, Bady E, Raedler JB, Simon R, Sauter G, Lennartz M, Büscheck F, Luebke AM, Dum D, Menz A, Höflmayer D, Weidemann S, Fraune C, Lebok P, et al. Nonredundant Upregulation of CD112R (PVRIG) and PD-1 on Cytotoxic T Lymphocytes Located in T Cell Nests of Colorectal Cancer. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 36: 100089. PMID 36788088 DOI: 10.1016/j.modpat.2022.100089 |
0.01 |
|
| 2023 |
Weidemann S, Gorbokon N, Lennartz M, Hube-Magg C, Fraune C, Bernreuther C, Clauditz TS, Jacobsen F, Jansen K, Schmalfeldt B, Wölber L, Paluchowski P, Berkes E, Heilenkötter U, Sauter G, ... ... Simon R, et al. High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer. Applied Immunohistochemistry & Molecular Morphology : Aimm. 31: 77-83. PMID 36728364 DOI: 10.1097/PAI.0000000000001097 |
0.01 |
|
| 2023 |
Möller K, Knöll M, Bady E, Schmerder MJ, Rico SD, Kluth M, Hube-Magg C, Blessin NC, Mandelkow T, Lennartz M, Menz A, Luebke AM, Höflmayer D, Fraune C, Bernreuther C, ... ... Simon R, et al. PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples. Cancer Biomarkers : Section a of Disease Markers. PMID 36683495 DOI: 10.3233/CBM-220030 |
0.01 |
|
| 2023 |
Blessin NC, Yang C, Mandelkow T, Raedler JB, Li W, Bady E, Simon R, Vettorazzi E, Lennartz M, Bernreuther C, Fraune C, Jacobsen F, Krech T, Marx A, Lebok P, et al. Automated Ki-67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistry. The Journal of Pathology. PMID 36656126 DOI: 10.1002/path.6057 |
0.01 |
|
| 2023 |
Reiswich V, Schmidt CE, Lennartz M, Höflmayer D, Hube-Magg C, Weidemann S, Fraune C, Büscheck F, Möller K, Bernreuther C, Simon R, Clauditz TS, Blessin NC, Bady E, Sauter G, et al. GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology. 1-14. PMID 36649695 DOI: 10.1159/000527382 |
0.01 |
|
| 2023 |
Nitschke C, Markmann B, Walter P, Badbaran A, Tölle M, Kropidlowski J, Belloum Y, Goetz MR, Bardenhagen J, Stern L, Tintelnot J, Schönlein M, Sinn M, van der Leest P, Simon R, et al. Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma. Clinical Chemistry. PMID 36644936 DOI: 10.1093/clinchem/hvac214 |
0.01 |
|
| 2022 |
Viehweger F, Azem A, Gorbokon N, Uhlig R, Lennartz M, Dwertmann Rico S, Kind S, Reiswich V, Kluth M, Hube-Magg C, Bernreuther C, Büscheck F, Clauditz TS, Fraune C, Jacobsen F, ... ... Simon R, et al. Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors. Pathology, Research and Practice. 240: 154200. PMID 36375372 DOI: 10.1016/j.prp.2022.154200 |
0.01 |
|
| 2022 |
Lennartz M, Atug D, Dwertmann Rico S, Reiswich V, Viehweger F, Büscheck F, Kluth M, Hube-Magg C, Hinsch A, Bernreuther C, Sauter G, Burandt E, Marx AH, Krech T, Simon R, et al. Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells. Diagnostics (Basel, Switzerland). 12. PMID 36292206 DOI: 10.3390/diagnostics12102516 |
0.01 |
|
| 2022 |
Weidemann S, Noori NA, Lennartz M, Reiswich V, Dum D, Menz A, Chirico V, Hube-Magg C, Fraune C, Bawahab AA, Bernreuther C, Simon R, Clauditz TS, Sauter G, Hinsch A, et al. Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 Tumors. Biomedicines. 10. PMID 36289769 DOI: 10.3390/biomedicines10102507 |
0.01 |
|
| 2022 |
Lennartz M, Ullmann VS, Gorbokon N, Uhlig R, Rico SD, Kind S, Reiswich V, Viehweger F, Kluth M, Hube-Magg C, Bernreuther C, Büscheck F, Putri D, Clauditz TS, Fraune C, ... ... Simon R, et al. Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. PMID 36269681 DOI: 10.1111/apm.13280 |
0.01 |
|
| 2022 |
Plage H, Samtleben H, Hofbauer S, Kornienko K, Weinberger S, Bruch PG, Elezkurtaj S, Roßner F, Schallenberg S, Kluth M, Lennartz M, Blessin NC, Marx AH, Fisch M, Rink M, ... ... Simon R, et al. GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder. Human Pathology. PMID 36152841 DOI: 10.1016/j.humpath.2022.09.004 |
0.01 |
|
| 2022 |
Uhlig R, Günther K, Bröker N, Gorbokon N, Lennartz M, Dwertmann Rico S, Reiswich V, Viehweger F, Büscheck F, Kluth M, Hube-Magg C, Hinsch A, Fraune C, Bernreuther C, Lebok P, ... ... Simon R, et al. Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumors. Pathology, Research and Practice. 238: 154123. PMID 36137400 DOI: 10.1016/j.prp.2022.154123 |
0.01 |
|
| 2022 |
Burandt E, Blessin NC, Rolschewski AC, Lutz F, Mandelkow T, Yang C, Bady E, Reiswich V, Simon R, Sauter G, Mahner S, Gregorio N, Klapdor R, Kalder M, Braicu EI, et al. T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell Cancer. Cancers. 14. PMID 36077784 DOI: 10.3390/cancers14174246 |
0.01 |
|
| 2022 |
Uhlig R, Abboud M, Gorbokon N, Lennartz M, Dwertmann Rico S, Kind S, Reiswich V, Viehweger F, Kluth M, Hube-Magg C, Bernreuther C, Büscheck F, Clauditz TS, Fraune C, Hinsch A, ... ... Simon R, et al. Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumors. Annals of Diagnostic Pathology. 60: 152029. PMID 36029589 DOI: 10.1016/j.anndiagpath.2022.152029 |
0.01 |
|
| 2022 |
Yamada Y, Bohnenberger H, Kriegsmann M, Kriegsmann K, Sinn P, Goto N, Nakanishi Y, Seno H, Chigusa Y, Fujimoto M, Minamiguchi S, Haga H, Simon R, Sauter G, Ströbel P, et al. Tuft cell-like carcinomas: novel cancer subsets present in multiple organs sharing a unique gene expression signature. British Journal of Cancer. PMID 35999270 DOI: 10.1038/s41416-022-01957-6 |
0.01 |
|
| 2022 |
Viehweger F, Tinger LM, Dum D, Gorbokon N, Menz A, Uhlig R, Büscheck F, Luebke AM, Hube-Magg C, Hinsch A, Höflmayer D, Fraune C, Lebok P, Weidemann S, Lennartz M, ... ... Simon R, et al. Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors. Analytical Cellular Pathology (Amsterdam). 2022: 6412148. PMID 35992051 DOI: 10.1155/2022/6412148 |
0.01 |
|
| 2022 |
Dum D, Ocokoljic A, Lennartz M, Hube-Magg C, Reiswich V, Höflmayer D, Jacobsen F, Bernreuther C, Lebok P, Sauter G, Luebke AM, Burandt E, Marx AH, Simon R, Clauditz TS, et al. FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors. Virchows Archiv : An International Journal of Pathology. PMID 35951102 DOI: 10.1007/s00428-022-03394-5 |
0.01 |
|
| 2022 |
Menz A, Gorbokon N, Viehweger F, Lennartz M, Hube-Magg C, Hornsteiner L, Kluth M, Völkel C, Luebke AM, Fraune C, Uhlig R, Minner S, Dum D, Höflmayer D, Sauter G, ... Simon R, et al. Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors. International Journal of Surgical Pathology. 10668969221117243. PMID 35946088 DOI: 10.1177/10668969221117243 |
0.01 |
|
| 2022 |
Uhlig R, Dum D, Gorbokon N, Menz A, Büscheck F, Luebke AM, Hube-Magg C, Hinsch A, Höflmayer D, Fraune C, Möller K, Bernreuther C, Lebok P, Weidemann S, Lennartz M, ... ... Simon R, et al. Synaptophysin and chromogranin A expression analysis in human tumors. Molecular and Cellular Endocrinology. 555: 111726. PMID 35921917 DOI: 10.1016/j.mce.2022.111726 |
0.01 |
|
| 2022 |
Singer CF, Holst F, Steurer S, Burandt EC, Lax SF, Jakesz R, Rudas M, Stöger H, Greil R, Sauter G, Filipits M, Simon R, Gnant M. Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. OF1-OF9. PMID 35920686 DOI: 10.1158/1078-0432.CCR-21-4328 |
0.01 |
|
| 2022 |
Dum D, Kromm D, Lennartz M, De Wispelaere N, Büscheck F, Luebke AM, Burandt E, Menz A, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Weidemann S, Fraune C, Möller K, ... ... Simon R, et al. SATB2 Expression in Human Tumors. Archives of Pathology & Laboratory Medicine. PMID 35917493 DOI: 10.5858/arpa.2021-0317-OA |
0.01 |
|
| 2022 |
Reiswich V, Könemann S, Lennartz M, Höflmayer D, Menz A, Chirico V, Hube-Magg C, Fraune C, Bernreuther C, Simon R, Clauditz TS, Sauter G, Hinsch A, Kind S, Jacobsen F, et al. Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer. Pathology, Research and Practice. 237: 154028. PMID 35872365 DOI: 10.1016/j.prp.2022.154028 |
0.01 |
|
| 2022 |
Dum D, Lennartz M, Menz A, Kluth M, Hube-Magg C, Weidemann S, Fraune C, Luebke AM, Hornsteiner L, Bernreuther C, Simon R, Clauditz TS, Sauter G, Uhlig R, Hinsch A, et al. Villin expression in human tumors: a tissue microarray study on 14,398 tumors. Expert Review of Molecular Diagnostics. 1-11. PMID 35866621 DOI: 10.1080/14737159.2022.2104122 |
0.01 |
|
| 2022 |
De Wispelaere N, Rico SD, Bauer M, Luebke AM, Kluth M, Büscheck F, Hube-Magg C, Höflmayer D, Gorbokon N, Weidemann S, Möller K, Fraune C, Bernreuther C, Simon R, Kähler C, et al. High prevalence of p16 staining in malignant tumors. Plos One. 17: e0262877. PMID 35862385 DOI: 10.1371/journal.pone.0262877 |
0.01 |
|
| 2022 |
Dwertmann Rico S, Büscheck F, Dum D, Luebke AM, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Perez D, Izbicki JR, Neipp M, Mofid H, Daniels T, Isbert C, Fraune C, ... ... Simon R, et al. Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma. International Journal of Immunopathology and Pharmacology. 36: 3946320221106504. PMID 35764407 DOI: 10.1177/03946320221106504 |
0.01 |
|
| 2022 |
Jansen K, Kluth M, Blessin NC, Hube-Magg C, Neipp M, Mofid H, Lárusson H, Daniels T, Isbert C, Coerper S, Ditterich D, Rupprecht H, Goetz A, Bernreuther C, Sauter G, ... ... Simon R, et al. DOG1 overexpression is associated with mismatch repair deficiency and BRAF mutations but unrelated to cancer progression in colorectal cancer. Histology and Histopathology. 18475. PMID 35642329 DOI: 10.14670/HH-18-475 |
0.01 |
|
| 2022 |
Lennartz M, Csomós H, Bernreuther C, Büscheck F, Fraune C, Simon R, Sauter G, Steurer S, Eichenauer T, Dahlem R, Fisch M, Riechardt S, Rink M, Minner S, Höflmayer D. Reduced CDH16 expression is linked to poor prognosis in clear cell renal cell carcinoma 16. Urologic Oncology. 40: 348.e1-348.e8. PMID 35606285 DOI: 10.1016/j.urolonc.2022.03.017 |
0.01 |
|
| 2022 |
Reiswich V, Akdeniz G, Lennartz M, Menz A, Chirico V, Hube-Magg C, Fraune C, Bernreuther C, Simon R, Clauditz TS, Sauter G, Uhlig R, Hinsch A, Kind S, Jacobsen F, et al. Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathology. Human Pathology. PMID 35550834 DOI: 10.1016/j.humpath.2022.05.002 |
0.01 |
|
| 2022 |
Dum D, Taherpour N, Menz A, Höflmayer D, Völkel C, Hinsch A, Gorbokon N, Lennartz M, Hube-Magg C, Fraune C, Bernreuther C, Lebok P, Clauditz TS, Jacobsen F, Sauter G, ... ... Simon R, et al. Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology. 1-14. PMID 35477165 DOI: 10.1159/000522206 |
0.01 |
|
| 2022 |
Fraune C, Burandt E, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kluth M, Büscheck F, Höflmayer D, Blessin NC, Mandelkow T, Li W, Perez D, Izbicki JR, Wilczak W, Sauter G, et al. Correction to: MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes. Annals of Surgical Oncology. PMID 35449481 DOI: 10.1245/s10434-022-11798-5 |
0.01 |
|
| 2022 |
Dum D, Menz A, Völkel C, De Wispelaere N, Hinsch A, Gorbokon N, Lennartz M, Luebke AM, Hube-Magg C, Kluth M, Fraune C, Möller K, Bernreuther C, Lebok P, Clauditz TS, ... ... Simon R, et al. Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers. Experimental and Molecular Pathology. 104762. PMID 35390310 DOI: 10.1016/j.yexmp.2022.104762 |
0.01 |
|
| 2022 |
Poos AM, Schroeder C, Jaishankar N, Röll D, Oswald M, Meiners J, Braun DM, Knotz C, Frank L, Gunkel M, Spilger R, Wollmann T, Polonski A, Makrypidi-Fraune G, Fraune C, ... ... Simon R, et al. PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power. Cancers. 14. PMID 35267575 DOI: 10.3390/cancers14051267 |
0.01 |
|
| 2022 |
Dum D, Henke TLC, Mandelkow T, Yang C, Bady E, Raedler JB, Simon R, Sauter G, Lennartz M, Büscheck F, Luebke AM, Menz A, Hinsch A, Höflmayer D, Weidemann S, et al. Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 35091676 DOI: 10.1038/s41374-022-00728-4 |
0.01 |
|
| 2022 |
Uhlig R, Contreras H, Weidemann S, Gorbokon N, Menz A, Büscheck F, Luebke AM, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Fraune C, Möller K, Bernreuther C, Lebok P, ... ... Simon R, et al. Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas. The American Journal of Surgical Pathology. 46: 97-104. PMID 34889867 DOI: 10.1097/PAS.0000000000001817 |
0.01 |
|
| 2021 |
Babbel J, Simon R, Macy E. Forget the Steroids, Pick Another Contrast to Prevent Contrast-Enhanced CT Reactions. The Journal of Allergy and Clinical Immunology. in Practice. 9: 4176-4177. PMID 36444002 DOI: 10.1016/j.jaip.2021.09.008 |
0.01 |
|
| 2021 |
Meiners J, Jansen K, Gorbokon N, Büscheck F, Luebke AM, Kluth M, Hube-Magg C, Höflmayer D, Weidemann S, Fraune C, Möller K, Bernreuther C, Lebok P, Menz A, Jacobsen F, ... ... Simon R, et al. Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 Tumours. Biomedicines. 9. PMID 34944647 DOI: 10.3390/biomedicines9121831 |
0.01 |
|
| 2021 |
Lennartz M, Gehrig E, Weidemann S, Gorbokon N, Menz A, Büscheck F, Hube-Magg C, Hinsch A, Reiswich V, Höflmayer D, Fraune C, Jacobsen F, Bernreuther C, Lebok P, Sauter G, ... ... Simon R, et al. Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular Carcinoma. Diagnostics (Basel, Switzerland). 11. PMID 34943588 DOI: 10.3390/diagnostics11122351 |
0.01 |
|
| 2021 |
Jansen K, Farahi N, Büscheck F, Lennartz M, Luebke AM, Burandt E, Menz A, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Weidemann S, Fraune C, Möller K, Lebok P, ... ... Simon R, et al. DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples. Pathology, Research and Practice. 228: 153663. PMID 34717148 DOI: 10.1016/j.prp.2021.153663 |
0.01 |
|
| 2021 |
Lebok P, Bönte H, Kluth M, Möller-Koop C, Witzel I, Wölber L, Paluchowski P, Wilke C, Heilenkötter U, Müller V, Schmalfeldt B, Simon R, Sauter G, Terracciano L, Krech RH, et al. 6q deletion is frequent but unrelated to patient prognosis in breast cancer. Breast Cancer (Tokyo, Japan). PMID 34625909 DOI: 10.1007/s12282-021-01301-5 |
0.01 |
|
| 2021 |
Völkel C, De Wispelaere N, Weidemann S, Gorbokon N, Lennartz M, Luebke AM, Hube-Magg C, Kluth M, Fraune C, Möller K, Bernreuther C, Lebok P, Clauditz TS, Jacobsen F, Sauter G, ... ... Simon R, et al. Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications. Virchows Archiv : An International Journal of Pathology. PMID 34559291 DOI: 10.1007/s00428-021-03204-4 |
0.01 |
|
| 2021 |
Rico SD, Mahnken M, Büscheck F, Dum D, Luebke AM, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Möller-Koop C, Fraune C, Möller K, Menz A, Bernreuther C, Jacobsen F, ... ... Simon R, et al. MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue Samples. Technology in Cancer Research & Treatment. 20: 15330338211043328. PMID 34547930 DOI: 10.1177/15330338211043328 |
0.01 |
|
| 2021 |
Lebok P, Schütt K, Kluth M, Witzel I, Wölber L, Paluchowski P, Terracciano L, Wilke C, Heilenkötter U, Müller V, Schmalfeldt B, Simon R, Sauter G, Von Leffern I, Krech T, et al. High mitochondrial content is associated with breast cancer aggressiveness. Molecular and Clinical Oncology. 15: 203. PMID 34462659 DOI: 10.3892/mco.2021.2365 |
0.01 |
|
| 2021 |
Steurer S, Schneider J, Büscheck F, Luebke AM, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Weidemann S, Fraune C, Möller K, Menz A, Bernreuther C, Lebok P, Sauter G, ... Simon R, et al. Immunohistochemically detectable thyroglobulin expression in extrathyroidal cancer is 100% specific for thyroidal tumor origin. Annals of Diagnostic Pathology. 54: 151793. PMID 34425503 DOI: 10.1016/j.anndiagpath.2021.151793 |
0.01 |
|
| 2021 |
Jansen K, Büscheck F, Moeller K, Kluth M, Hube-Magg C, Blessin NC, Perez D, Izbicki J, Neipp M, Mofid H, Daniels T, Nahrstedt U, Fraune C, Jacobsen F, Bernreuther C, ... ... Simon R, et al. DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness. Peerj. 9: e11905. PMID 34414034 DOI: 10.7717/peerj.11905 |
0.01 |
|
| 2021 |
Reiswich V, Gorbokon N, Luebke AM, Burandt E, Menz A, Kluth M, Hube-Magg C, Wittmer C, Weidemann S, Fraune C, Möller K, Lebok P, Sauter G, Simon R, Uhlig R, et al. Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumors. The Journal of Pathology. Clinical Research. PMID 34363325 DOI: 10.1002/cjp2.237 |
0.01 |
|
| 2021 |
Velthaus JL, Iglauer P, Simon R, Bokemeyer C, Bannas P, Beumer N, Imbusch CD, Goekkurt E, Loges S. Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 p.L1950F Mutation: Case Report. Oncology Research and Treatment. 1-7. PMID 34320493 DOI: 10.1159/000517616 |
0.01 |
|
| 2021 |
Weidemann S, Böhle JL, Contreras H, Luebke AM, Kluth M, Büscheck F, Hube-Magg C, Höflmayer D, Möller K, Fraune C, Bernreuther C, Rink M, Simon R, Menz A, Hinsch A, et al. Napsin A Expression in Human Tumors and Normal Tissues. Pathology Oncology Research : Por. 27: 613099. PMID 34257582 DOI: 10.3389/pore.2021.613099 |
0.01 |
|
| 2021 |
Weidemann S, Böhle JL, Contreras H, Luebke AM, Kluth M, Büscheck F, Hube-Magg C, Höflmayer D, Möller K, Fraune C, Bernreuther C, Rink M, Simon R, Menz A, Hinsch A, et al. Napsin A Expression in Human Tumors and Normal Tissues. Pathology Oncology Research : Por. 27: 613099. PMID 34257582 DOI: 10.3389/pore.2021.613099 |
0.01 |
|
| 2021 |
Rico SD, Schmalfeldt B, Müller V, Wölber L, Witzel I, Paluchowski P, von Leffern I, Heilenkötter U, Jacobsen F, Bernreuther C, Clauditz T, Simon R, Steurer S, Burandt E, Marx AH, et al. MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancer. Pathology, Research and Practice. 224: 153533. PMID 34171599 DOI: 10.1016/j.prp.2021.153533 |
0.01 |
|
| 2021 |
Bellon E, Grupp K, Ghadban T, Tachezy M, Bachmann K, Izbicki JR, Simon R, Sauter G, Hube-Magg C, Melling N. Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients. Journal of Cancer Research and Clinical Oncology. PMID 34148155 DOI: 10.1007/s00432-021-03686-4 |
0.01 |
|
| 2021 |
Bellon E, Grupp K, Ghadban T, Tachezy M, Bachmann K, Izbicki JR, Simon R, Sauter G, Hube-Magg C, Melling N. Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients. Journal of Cancer Research and Clinical Oncology. PMID 34148155 DOI: 10.1007/s00432-021-03686-4 |
0.01 |
|
| 2021 |
Weidemann S, Perez D, Izbicki JR, Neipp M, Mofid H, Daniels T, Nahrstedt U, Jacobsen F, Bernreuther C, Simon R, Steurer S, Burandt E, Marx AH, Krech T, Clauditz TS, et al. Mesothelin is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness. Cancer Investigation. 1-20. PMID 34143695 DOI: 10.1080/07357907.2021.1943747 |
0.01 |
|
| 2021 |
Weidemann S, Perez D, Izbicki JR, Neipp M, Mofid H, Daniels T, Nahrstedt U, Jacobsen F, Bernreuther C, Simon R, Steurer S, Burandt E, Marx AH, Krech T, Clauditz TS, et al. Mesothelin is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness. Cancer Investigation. 1-20. PMID 34143695 DOI: 10.1080/07357907.2021.1943747 |
0.01 |
|
| 2021 |
Menz A, Bauer R, Kluth M, Marie von Bargen C, Gorbokon N, Viehweger F, Lennartz M, Völkl C, Fraune C, Uhlig R, Hube-Magg C, De Wispelaere N, Minner S, Sauter G, Kind S, ... Simon R, et al. Diagnostic and prognostic impact of Cytokeratin 19 expression analysis in human tumors: A tissue microarray study of 13,172 tumors. Human Pathology. PMID 34102222 DOI: 10.1016/j.humpath.2021.05.012 |
0.01 |
|
| 2021 |
Möller K, Blessin NC, Höflmayer D, Büscheck F, Luebke AM, Kluth M, Hube-Magg C, Zalewski K, Hinsch A, Neipp M, Mofid H, Lárusson H, Daniels T, Isbert C, Coerper S, ... ... Simon R, et al. High density of cytotoxic T-lymphocytes is linked to tumoral PD-L1 expression regardless of the mismatch repair status in colorectal cancer. Acta Oncologica (Stockholm, Sweden). 1-8. PMID 34092167 DOI: 10.1080/0284186X.2021.1933585 |
0.01 |
|
| 2021 |
Burandt E, Lübbersmeyer F, Gorbokon N, Büscheck F, Luebke AM, Menz A, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Weidemann S, Fraune C, Möller K, Jacobsen F, Lebok P, ... ... Simon R, et al. E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors. Biomarker Research. 9: 44. PMID 34090526 DOI: 10.1186/s40364-021-00299-4 |
0.01 |
|
| 2021 |
Blessin NC, Abu-Hashem R, Mandelkow T, Li W, Simon R, Hube-Magg C, Möller-Koop C, Witt M, Schmidt A, Büscheck F, Fraune C, Luebke AM, Möller K, Jacobsen F, Lutz F, et al. Prevalence of proliferating CD8 cells in normal lymphatic tissues, inflammation and cancer. Aging. 13. PMID 34083496 DOI: 10.18632/aging.203113 |
0.01 |
|
| 2021 |
Weidemann S, Gagelmann P, Gorbokon N, Lennartz M, Menz A, Luebke AM, Kluth M, Hube-Magg C, Blessin NC, Fraune C, Möller K, Bernreuther C, Lebok P, Clauditz TS, Jacobsen F, ... ... Simon R, et al. Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors. Biomedicines. 9. PMID 33917081 DOI: 10.3390/biomedicines9040397 |
0.01 |
|
| 2021 |
Blessin NC, Li W, Mandelkow T, Jansen HL, Yang C, Raedler JB, Simon R, Büscheck F, Dum D, Luebke AM, Hinsch A, Möller K, Menz A, Bernreuther C, Lebok P, et al. Prognostic role of proliferating CD8 cytotoxic Tcells in human cancers. Cellular Oncology (Dordrecht). PMID 33864611 DOI: 10.1007/s13402-021-00601-4 |
0.01 |
|
| 2021 |
Dum D, Steurer S, Simon R, Zimmermann PV, Burandt E, Clauditz TS, Fisch M, Rink M, Dahlem R, Höppner W, Zecha H, Doh O, Matthies C, Wilczak W, Sauter G, et al. Mismatch repair deficiency occurs very rarely in seminomas. Translational Andrology and Urology. 10: 1048-1055. PMID 33850739 DOI: 10.21037/tau-20-1355 |
0.01 |
|
| 2021 |
Möller K, Fraune C, Blessin NC, Lennartz M, Kluth M, Hube-Magg C, Lindhorst L, Dahlem R, Fisch M, Eichenauer T, Riechardt S, Simon R, Sauter G, Büscheck F, Höppner W, et al. Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer. International Urology and Nephrology. PMID 33797012 DOI: 10.1007/s11255-021-02841-7 |
0.01 |
|
| 2021 |
Büscheck F, Fraune C, Garmestani S, Simon R, Kluth M, Hube-Magg C, Ketterer K, Eichelberg C, Höflmayer D, Jacobsen F, Wittmer C, Wilczak W, Sauter G, Fisch M, Eichenauer T, et al. Y-chromosome loss is frequent in male renal tumors. Annals of Translational Medicine. 9: 209. PMID 33708836 DOI: 10.21037/atm-20-3061 |
0.01 |
|
| 2021 |
Marx A, Koopmann L, Höflmayer D, Büscheck F, Hube-Magg C, Steurer S, Eichenauer T, Clauditz TS, Wilczak W, Simon R, Sauter G, Izbicki JR, Huland H, Heinzer H, Graefen M, et al. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer. Cancer Biology & Medicine. 18: 245-255. PMID 33628598 DOI: 10.20892/j.issn.2095-3941.2019.0324 |
0.01 |
|
| 2021 |
Menz A, Weitbrecht T, Gorbokon N, Büscheck F, Luebke AM, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Weidemann S, Fraune C, Möller K, Bernreuther C, Lebok P, Clauditz T, ... ... Simon R, et al. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors. Molecular Medicine (Cambridge, Mass.). 27: 16. PMID 33588765 DOI: 10.1186/s10020-021-00274-7 |
0.01 |
|
| 2021 |
Spethmann T, Böckelmann LC, Labitzky V, Ahlers AK, Schröder-Schwarz J, Bonk S, Simon R, Sauter G, Huland H, Kypta R, Schumacher U, Lange T. Opposing prognostic relevance of junction plakoglobin in distinct prostate cancer patient subsets. Molecular Oncology. PMID 33533127 DOI: 10.1002/1878-0261.12922 |
0.01 |
|
| 2021 |
Steurer S, Riemann C, Büscheck F, Luebke AM, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Weidemann S, Fraune C, Möller K, Menz A, Fisch M, Rink M, Bernreuther C, ... ... Simon R, et al. p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors. Biomarker Research. 9: 7. PMID 33494829 DOI: 10.1186/s40364-021-00260-5 |
0.01 |
|
| 2021 |
Höflmayer D, Fraune C, Hube-Magg C, Simon R, Schroeder C, Büscheck F, Möller K, Dum D, Weidemann S, Wittmer C, Schlomm T, Huland H, Heinzer H, Graefen M, Haese A, et al. Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate Cancer. Applied Immunohistochemistry & Molecular Morphology : Aimm. PMID 33491944 DOI: 10.1097/PAI.0000000000000901 |
0.01 |
|
| 2021 |
Cook KA, Domissy A, Simon RA, White AA, Modena BD. Dysbiosis in aspirin-exacerbated respiratory disease. International Forum of Allergy & Rhinology. PMID 33438331 DOI: 10.1002/alr.22762 |
0.01 |
|
| 2021 |
Oh-Hohenhorst SJ, Tilki D, Ahlers AK, Suling A, Hahn O, Tennstedt P, Matuszcak C, Maar H, Labitzky V, Hanika S, Starzonek S, Baumgart S, Johnsen SA, Kluth M, Sirma H, ... Simon R, et al. CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo. Cancer Gene Therapy. PMID 33414516 DOI: 10.1038/s41417-020-00288-z |
0.01 |
|
| 2020 |
Rico SD, Höflmayer D, Büscheck F, Dum D, Luebke AM, Kluth M, Hube-Magg C, Hinsch A, Möller-Koop C, Perez D, Izbicki JR, Neipp M, Mofid H, Lárusson H, Daniels T, ... ... Simon R, et al. Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancer. Medical Molecular Morphology. PMID 33373033 DOI: 10.1007/s00795-020-00274-2 |
0.01 |
|
| 2020 |
Freytag M, Kluth M, Bady E, Hube-Magg C, Makrypidi-Fraune G, Heinzer H, Höflmayer D, Weidemann S, Uhlig R, Huland H, Graefen M, Bernreuther C, Wittmer C, Tsourlakis MC, Minner S, ... ... Simon R, et al. Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer. Bmc Cancer. 20: 1220. PMID 33339518 DOI: 10.1186/s12885-020-07682-8 |
0.01 |
|
| 2020 |
White AA, Woessner K, Simon R. Aspirin-exacerbated respiratory disease: Update on medical management. World Journal of Otorhinolaryngology - Head and Neck Surgery. 6: 241-247. PMID 33336180 DOI: 10.1016/j.wjorl.2020.07.009 |
0.01 |
|
| 2020 |
Kind S, Kluth M, Hube-Magg C, Möller K, Makrypidi-Fraune G, Lutz F, Lennartz M, Rico SD, Schlomm T, Heinzer H, Höflmayer D, Weidemann S, Uhlig R, Huland H, Graefen M, ... ... Simon R, et al. Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence. Biomed Research International. 2020: 5845374. PMID 33195694 DOI: 10.1155/2020/5845374 |
0.01 |
|
| 2020 |
Belloum Y, Janning M, Mohme M, Simon R, Kropidlowski J, Sartori A, Irwin D, Westphal M, Lamszus K, Loges S, Riethdorf S, Pantel K, Wikman H. Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay. Cells. 9. PMID 33105541 DOI: 10.3390/cells9112337 |
0.01 |
|
| 2020 |
Voß H, Wurlitzer M, Smit DJ, Ewald F, Alawi M, Spohn M, Indenbirken D, Omidi M, David K, Juhl H, Simon R, Sauter G, Fischer L, Izbicki JR, Molloy MP, et al. Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer. Clinical & Experimental Metastasis. PMID 33099724 DOI: 10.1007/s10585-020-10058-8 |
0.01 |
|
| 2020 |
Möller K, Kluth M, Ahmed M, Burkhardt L, Möller-Koop C, Büscheck F, Weidemann S, Tsourlakis MC, Minner S, Heinzer H, Huland H, Graefen M, Sauter G, Schlomm T, Dum D, ... Simon R, et al. Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancer. International Journal of Cancer. PMID 33045100 DOI: 10.1002/ijc.33344 |
0.01 |
|
| 2020 |
Pasternack JB, Ciminero ML, Silver M, Chang J, Simon RJ, Kang KK. Effect of weekend admission on geriatric hip fractures. World Journal of Orthopedics. 11: 391-399. PMID 32999859 DOI: 10.5312/wjo.v11.i9.391 |
0.01 |
|
| 2020 |
Bonk S, Tasdelen P, Kluth M, Hube-Magg C, Makrypidi-Fraune G, Möller K, Höflmayer D, Dwertmann Rico S, Büscheck F, Minner S, Heinzer H, Graefen M, Hinsch A, Luebke AM, Dum D, ... ... Simon R, et al. High B7-H3 expression is linked to increased risk of prostate cancer progression. Pathology International. PMID 32776718 DOI: 10.1111/pin.12999 |
0.01 |
|
| 2020 |
Lange T, Samatov TR, Galatenko VV, Steffen P, von Kriegstein H, Spethmann T, Wicklein D, Maar H, Kupfernagel K, Labitzky V, Hanika S, Starzonek S, Ahlers AK, Riecken K, Simon R, et al. Xenograft-derived mRNA/miR and protein interaction networks of systemic dissemination in human prostate cancer. European Journal of Cancer (Oxford, England : 1990). 137: 93-107. PMID 32750503 DOI: 10.1016/j.ejca.2020.06.025 |
0.01 |
|
| 2020 |
Schaks M, Allgoewer K, Nelson N, Ehm P, Heumann A, Ewald F, Schumacher U, Simon R, Sauter G, Jücker M. Ectopic Expression of Hematopoietic SHIP1 in Human Colorectal Cancer. Biomedicines. 8. PMID 32679836 DOI: 10.3390/biomedicines8070215 |
0.01 |
|
| 2020 |
Bernreuther C, Daghigh F, Möller K, Hube-Magg C, Lennartz M, Lutz F, Rico SD, Fraune C, Dum D, Luebke AM, Eichenauer T, Möller-Koop C, Schlomm T, Wittmer C, Huland H, ... ... Simon R, et al. Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions. Pathology Oncology Research : Por. PMID 32677026 DOI: 10.1007/s12253-020-00861-9 |
0.01 |
|
| 2020 |
Bonk S, Kluth M, Jansen K, Hube-Magg C, Makrypidi-Fraune G, Höflmayer D, Weidemann S, Möller K, Uhlig R, Büscheck F, Luebke AM, Burandt E, Clauditz TS, Steurer S, Schlomm T, ... ... Simon R, et al. Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer. The Prostate. PMID 32628300 DOI: 10.1002/pros.24038 |
0.01 |
|
| 2020 |
Kempski J, Giannou AD, Riecken K, Zhao L, Steglich B, Lücke J, Garcia-Perez L, Karstens KF, Wöstemeier A, Nawrocki M, Pelczar P, Witkowski M, Nilsson S, Konczalla L, Shiri AM, ... ... Simon R, et al. IL22BP Mediates the Anti-Tumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and Humans. Gastroenterology. PMID 32585307 DOI: 10.1053/J.Gastro.2020.06.033 |
0.01 |
|
| 2020 |
Eichenauer T, Shadanpour N, Kluth M, Göbel C, Weidemann S, Fraune C, Büscheck F, Hube-Magg C, Möller-Koop C, Dahlem R, Fisch M, Rink M, Riechardt S, Burandt E, Bernreuther C, ... ... Simon R, et al. Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma. World Journal of Surgical Oncology. 18: 128. PMID 32534597 DOI: 10.1186/s12957-020-01902-y |
0.01 |
|
| 2020 |
Marx A, Schumann A, Höflmayer D, Bady E, Hube-Magg C, Möller K, Tsourlakis MC, Steurer S, Büscheck F, Eichenauer T, Clauditz TS, Graefen M, Simon R, Sauter G, Izbicki JR, et al. Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers. Scientific Reports. 10: 8916. PMID 32488048 DOI: 10.1038/S41598-020-65772-W |
0.01 |
|
| 2020 |
Möller K, Wecker AL, Höflmayer D, Fraune C, Makrypidi-Fraune G, Hube-Magg C, Kluth M, Steurer S, Clauditz TS, Wilczak W, Simon R, Sauter G, Huland H, Heinzer H, Haese A, et al. Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers. Virchows Archiv : An International Journal of Pathology. PMID 32417965 DOI: 10.1007/S00428-020-02834-4 |
0.01 |
|
| 2020 |
Marx A, Luebke AM, Clauditz TS, Steurer S, Fraune C, Hube-Magg C, Büscheck F, Höflmayer D, Tsourlakis MC, Möller-Koop C, Simon R, Sauter G, Göbel C, Lebok P, Dum D, et al. Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer. Disease Markers. 2020: 7050146. PMID 32377272 DOI: 10.1155/2020/7050146 |
0.01 |
|
| 2020 |
Büscheck F, Fraune C, Kluth M, Lennartz M, Simon R, Hube-Magg C, Morlock C, Barbieri S, Wahl C, Eichelberg C, Möller-Koop C, Höflmayer D, Wittmer C, Wilczak W, Sauter G, et al. A non-diploid DNA status is linked to poor prognosis in renal cell cancer. World Journal of Urology. PMID 32361874 DOI: 10.1007/s00345-020-03226-8 |
0.01 |
|
| 2020 |
Eichenauer T, Federlein F, Möller K, Chirico V, Kind S, Lennartz M, Lutz F, Hube-Magg C, Höflmayer D, Fisch M, Huland H, Heinzer H, Graefen M, Haese A, Schroeder C, ... ... Simon R, et al. High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer. Pathology. PMID 32317175 DOI: 10.1016/j.pathol.2020.03.001 |
0.01 |
|
| 2020 |
Fraune C, Yehorov S, Luebke AM, Steurer S, Hube-Magg C, Büscheck F, Höflmayer D, Tsourlakis MC, Clauditz TS, Simon R, Sauter G, Weidemann S, Dum D, Kind S, Minner S, et al. Upregulation of PTTG1 is associated with poor prognosis in prostate cancer. Pathology International. PMID 32314536 DOI: 10.1111/pin.12938 |
0.01 |
|
| 2020 |
Eichenauer T, Simmendinger L, Fraune C, Mandelkow T, Blessin NC, Kluth M, Hube-Magg C, Möller K, Clauditz T, Weidemann S, Dahlem R, Fisch M, Riechardt S, Simon R, Sauter G, et al. High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma. World Journal of Urology. PMID 32303902 DOI: 10.1007/s00345-020-03200-4 |
0.01 |
|
| 2020 |
Jacobsen F, Kohsar J, Gebauer F, Kluth M, Hube-Magg C, Simon R, Bockhorn M, Hinsch A, Burandt E, Lübke AM, Steurer S, Tachezy M, Sauter G, Izbicki JR, Wilczak W, et al. Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinoma. Oncotarget. 11: 1007-1016. PMID 32256975 DOI: 10.18632/oncotarget.27507 |
0.01 |
|
| 2020 |
Eichenauer T, Simmendinger L, Kluth M, Chirico V, Luebke AM, Höflmayer D, Hinsch A, Jacobsen F, Hube-Magg C, Möller-Koop C, Dahlem R, Fisch M, Rink M, Riechardt S, Tsourlakis MC, ... ... Simon R, et al. Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer. Urologic Oncology. PMID 32241691 DOI: 10.1016/j.urolonc.2020.02.022 |
0.01 |
|
| 2020 |
Luebke AM, Ricken W, Kluth M, Hube-Magg C, Schroeder C, Büscheck F, Möller K, Dum D, Höflmayer D, Weidemann S, Fraune C, Hinsch A, Wittmer C, Schlomm T, Huland H, ... ... Simon R, et al. Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers. International Journal of Cancer. PMID 32150281 DOI: 10.1002/ijc.32957 |
0.01 |
|
| 2020 |
Fraune C, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kluth M, Büscheck F, Amin T, Viol F, Fehrle W, Dum D, Höflmayer D, Burandt E, Clauditz TS, Perez D, Izbicki J, et al. Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas. Endocrine Pathology. PMID 32144630 DOI: 10.1007/s12022-020-09612-7 |
0.01 |
|
| 2020 |
Fraune C, Harms L, Büscheck F, Höflmayer D, Tsourlakis MC, Clauditz TS, Simon R, Möller K, Luebke AM, Möller-Koop C, Steurer S, Hube-Magg C, Sauter G, Weidemann S, Lebok P, et al. Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion. Molecular Medicine (Cambridge, Mass.). 26: 24. PMID 32143573 DOI: 10.1186/s10020-020-00148-4 |
0.01 |
|
| 2020 |
Blessin NC, Spriestersbach P, Li W, Mandelkow T, Dum D, Simon R, Hube-Magg C, Lutz F, Viehweger F, Lennartz M, Fraune C, Nickelsen V, Fehrle W, Göbel C, Weidemann S, et al. Prevalence of CD8 cytotoxic lymphocytes in human neoplasms. Cellular Oncology (Dordrecht). PMID 32141029 DOI: 10.1007/s13402-020-00496-7 |
0.01 |
|
| 2020 |
Fraune C, Burandt E, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kluth M, Büscheck F, Höflmayer D, Blessin NC, Mandelkow T, Li W, Perez D, Izbicki JR, Wilczak W, Sauter G, et al. MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes. Annals of Surgical Oncology. PMID 32108923 DOI: 10.1245/s10434-020-08209-y |
0.01 |
|
| 2020 |
Büscheck F, Fraune C, Simon R, Kluth M, Hube-Magg C, Möller-Koop C, Sarper I, Ketterer K, Henke T, Eichelberg C, Dahlem R, Wilczak W, Sauter G, Fisch M, Eichenauer T, et al. Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes. Oncotarget. 11: 237-249. PMID 32076485 DOI: 10.18632/oncotarget.27428 |
0.01 |
|
| 2020 |
Fraune C, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kähler C, Kluth M, Höflmayer D, Büscheck F, Dum D, Luebke AM, Burandt E, Clauditz TS, Wilczak W, Sauter G, Steurer S. MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass. Urologic Oncology. PMID 32067846 DOI: 10.1016/j.urolonc.2019.12.012 |
0.01 |
|
| 2020 |
Pietrzak K, Kuzyakiv R, Simon R, Bolis M, Bär D, Aprigliano R, Theurillat JP, Sauter G, Santoro R. TIP5 primes prostate luminal cells for the oncogenic transformation mediated by -loss. Proceedings of the National Academy of Sciences of the United States of America. PMID 32024754 DOI: 10.1073/pnas.1911673117 |
0.01 |
|
| 2020 |
von Loga K, Woolston A, Punta M, Barber LJ, Griffiths B, Semiannikova M, Spain G, Challoner B, Fenwick K, Simon R, Marx A, Sauter G, Lise S, Matthews N, Gerlinger M. Author Correction: Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer. Nature Communications. 11: 675. PMID 31996672 DOI: 10.1038/S41467-020-14602-8 |
0.01 |
|
| 2020 |
von Loga K, Woolston A, Punta M, Barber LJ, Griffiths B, Semiannikova M, Spain G, Challoner B, Fenwick K, Simon R, Marx A, Sauter G, Lise S, Matthews N, Gerlinger M. Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer. Nature Communications. 11: 139. PMID 31949146 DOI: 10.1038/S41467-019-13915-7 |
0.01 |
|
| 2020 |
Fraune C, Rosebrock J, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kluth M, Büscheck F, Höflmayer D, Schmalfeldt B, Müller V, Wölber L, Witzel I, Paluchowski P, Wilke C, Heilenkötter U, et al. High homogeneity of MMR deficiency in ovarian cancer. Gynecologic Oncology. PMID 31924330 DOI: 10.1016/j.ygyno.2019.12.031 |
0.01 |
|
| 2020 |
Büscheck F, Sulimankhil M, Melling N, Höflmayer D, Hube-Magg C, Simon R, Göbel C, Hinsch A, Weidemann S, Izbicki JR, Jacobsen F, Mandelkow T, Blessin NC, Möller-Koop C, Lutz F, et al. Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients. Cancer Medicine. PMID 31893572 DOI: 10.1002/cam4.2773 |
0.01 |
|
| 2020 |
Fahrenholz J, Simon R. Food Allergy. Current Treatment Options in Gastroenterology. 5: 39-42. PMID 11792236 DOI: 10.1007/s11938-002-0005-2 |
0.01 |
|
| 2019 |
Kind S, Merenkow C, Büscheck F, Möller K, Dum D, Chirico V, Luebke AM, Höflmayer D, Hinsch A, Jacobsen F, Göbel C, Weidemann S, Fraune C, Möller-Koop C, Hube-Magg C, ... ... Simon R, et al. Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues. Disease Markers. 2019: 4928315. PMID 31976021 DOI: 10.1155/2019/4928315 |
0.01 |
|
| 2019 |
Steurer S, Schwemmer L, Hube-Magg C, Büscheck F, Höflmayer D, Tsourlakis MC, Clauditz TS, Luebke AM, Simon R, Sauter G, Izbicki J, Schroeder C, Schlomm T, Huland H, Heinzer H, et al. Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion. Oncotarget. 10: 7096-7111. PMID 31903168 DOI: 10.18632/oncotarget.27270 |
0.01 |
|
| 2019 |
Marx AH, Mickler C, Sauter G, Simon R, Terracciano LM, Izbicki JR, Clauditz TS. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer. International Journal of Colorectal Disease. PMID 31838579 DOI: 10.1007/s00384-019-03478-w |
0.01 |
|
| 2019 |
Fraune C, Simon R, Höflmayer D, Möller K, Dum D, Büscheck F, Hube-Magg C, Makrypidi-Fraune G, Kluth M, Hinsch A, Burandt E, Clauditz TS, Wilczak W, Sauter G, Steurer S. High homogeneity of mismatch repair deficiency in advanced prostate cancer. Virchows Archiv : An International Journal of Pathology. PMID 31811435 DOI: 10.1007/s00428-019-02701-x |
0.01 |
|
| 2019 |
Eichenauer T, Bannenberg DC, Kluth M, Wittmer C, Büscheck F, Möller K, Dum D, Fraune C, Hube-Magg C, Möller-Koop C, Dahlem R, Fisch M, Rink M, Riechardt S, Tsourlakis MC, ... ... Simon R, et al. 8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival. Urologic Oncology. PMID 31757738 DOI: 10.1016/j.urolonc.2019.09.024 |
0.01 |
|
| 2019 |
Kind S, Büscheck F, Höflmayer D, Hube-Magg C, Kluth M, Tsourlakis MC, Steurer S, Clauditz TS, Luebke AM, Burandt E, Wilczak W, Hinsch A, Dum D, Weidemann S, Fraune C, ... ... Simon R, et al. Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer. World Journal of Urology. PMID 31745645 DOI: 10.1007/s00345-019-03017-w |
0.01 |
|
| 2019 |
Höflmayer D, Steinhoff A, Hube-Magg C, Kluth M, Simon R, Burandt E, Tsourlakis MC, Minner S, Sauter G, Büscheck F, Wilczak W, Steurer S, Huland H, Graefen M, Haese A, et al. Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer. Molecular Oncology. PMID 31736271 DOI: 10.1002/1878-0261.12597 |
0.01 |
|
| 2019 |
Höflmayer D, Hamuda M, Schroeder C, Hube-Magg C, Simon R, Göbel C, Hinsch A, Weidemann S, Möller K, Izbicki JR, Jacobsen F, Mandelkow T, Blessin NC, Lutz F, Viehweger F, et al. High RSF1 protein expression is an independent prognostic feature in prostate cancer. Acta Oncologica (Stockholm, Sweden). 1-6. PMID 31687881 DOI: 10.1080/0284186X.2019.1686537 |
0.01 |
|
| 2019 |
Luskin KT, Bosso JV, Simon RA. Intranasal Ketorolac-Induced Pancreatitis as a Complication of Modified Oral Aspirin Desensitization in a Patient with Aspirin-Exacerbated Respiratory Disease. The Journal of Allergy and Clinical Immunology. in Practice. PMID 31678291 DOI: 10.1016/j.jaip.2019.10.006 |
0.01 |
|
| 2019 |
Toth R, Schiffmann H, Hube-Magg C, Büscheck F, Höflmayer D, Weidemann S, Lebok P, Fraune C, Minner S, Schlomm T, Sauter G, Plass C, Assenov Y, Simon R, Meiners J, et al. Random forest-based modelling to detect biomarkers for prostate cancer progression. Clinical Epigenetics. 11: 148. PMID 31640781 DOI: 10.1186/S13148-019-0736-8 |
0.01 |
|
| 2019 |
Meiners J, Schulz K, Möller K, Höflmayer D, Burdelski C, Hube-Magg C, Simon R, Göbel C, Hinsch A, Reiswich V, Weidemann S, Izbicki JR, Sauter G, Jacobsen F, Möller-Koop C, et al. Upregulation of SPDEF is associated with poor prognosis in prostate cancer. Oncology Letters. 18: 5107-5118. PMID 31612022 DOI: 10.3892/ol.2019.10885 |
0.01 |
|
| 2019 |
Weidemann SA, Sauer C, Luebke AM, Möller-Koop C, Steurer S, Hube-Magg C, Büscheck F, Höflmayer D, Tsourlakis MC, Clauditz TS, Simon R, Sauter G, Göbel C, Lebok P, Dum D, et al. High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer. Bmc Cancer. 19: 944. PMID 31606028 DOI: 10.1186/s12885-019-6182-3 |
0.01 |
|
| 2019 |
Steurer S, Hager B, Büscheck F, Höflmayer D, Tsourlakis MC, Minner S, Clauditz TS, Hube-Magg C, Luebke AM, Simon R, Izbicki JR, Burandt E, Sauter G, Fraune C, Weidemann S, et al. Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer. Aging. 11. PMID 31557128 DOI: 10.18632/aging.102294 |
0.01 |
|
| 2019 |
Kind S, Jaretzke A, Büscheck F, Möller K, Dum D, Höflmayer D, Hinsch A, Weidemann S, Fraune C, Möller-Koop C, Hube-Magg C, Simon R, Wilczak W, Lebok P, Witzel I, et al. A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer. Molecular Carcinogenesis. PMID 31545001 DOI: 10.1002/mc.23119 |
0.01 |
|
| 2019 |
Bonk S, Kluth M, Hube-Magg C, Polonski A, Soekeland G, Makropidi-Fraune G, Möller-Koop C, Witt M, Luebke AM, Hinsch A, Burandt E, Steurer S, Clauditz TS, Schlomm T, Perez D, ... ... Simon R, et al. Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues. Oncotarget. 10: 5439-5453. PMID 31534629 DOI: 10.18632/oncotarget.27145 |
0.01 |
|
| 2019 |
Lebok P, von Hassel A, Meiners J, Hube-Magg C, Simon R, Höflmayer D, Hinsch A, Dum D, Fraune C, Göbel C, Möller K, Sauter G, Jacobsen F, Büscheck F, Prien K, et al. Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer. Aging. 11. PMID 31533087 DOI: 10.18632/aging.102287 |
0.01 |
|
| 2019 |
Luebke AM, Attarchi-Tehrani A, Meiners J, Hube-Magg C, Lang DS, Kluth M, Tsourlakis MC, Minner S, Simon R, Sauter G, Büscheck F, Jacobsen F, Hinsch A, Steurer S, Schlomm T, et al. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of deleted prostate cancers. Cancer Biology & Medicine. 16: 319-330. PMID 31516752 DOI: 10.20892/j.issn.2095-3941.2018.0384 |
0.01 |
|
| 2019 |
Schroeder C, Navid-Hill E, Meiners J, Hube-Magg C, Kluth M, Makrypidi-Fraune G, Simon R, Büscheck F, Luebke AM, Goebel C, Lang DS, Weidemann S, Neubauer E, Hinsch A, Jacobsen F, et al. Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy. Oncotarget. 10: 4973-4986. PMID 31452838 DOI: 10.18632/oncotarget.27132 |
0.01 |
|
| 2019 |
Hinsch A, Blessin NC, Simon R, Kluth M, Fischer K, Hube-Magg C, Li W, Makrypidi-Fraune G, Wellge B, Mandelkow T, Debatin NF, Höflmayer D, Lennartz M, Sauter G, Izbicki JR, et al. Expression of the immune checkpoint receptor TIGIT in seminoma. Oncology Letters. 18: 1497-1502. PMID 31423216 DOI: 10.3892/ol.2019.10428 |
0.01 |
|
| 2019 |
Savel RH, Shiloh AL, Simon RJ, Kupfer Y. Getting It Right for Our Patients: The Importance of Collaborative Leadership in the ICU. Critical Care Medicine. 47: 1279-1281. PMID 31415316 DOI: 10.1097/CCM.0000000000003880 |
0.01 |
|
| 2019 |
Minner S, Hager D, Steurer S, Höflmayer D, Tsourlakis MC, Möller-Koop C, Clauditz TS, Hube-Magg C, Luebke AM, Simon R, Sauter G, Göbel C, Weidemann S, Lebok P, Dum D, et al. Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy. Neoplasia (New York, N.Y.). 21: 872-881. PMID 31382165 DOI: 10.1016/j.neo.2019.07.003 |
0.01 |
|
| 2019 |
Büscheck F, Zub M, Heumann A, Hube-Magg C, Simon R, Lang DS, Höflmayer D, Neubauer E, Jacobsen F, Hinsch A, Luebke AM, Tsourlakis MC, Sauter G, Huland H, Graefen M, et al. The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 41: 1010428318824815. PMID 31296150 DOI: 10.1177/1010428318824815 |
0.01 |
|
| 2019 |
Janning M, Kobus F, Babayan A, Wikman H, Velthaus JL, Bergmann S, Schatz S, Falk M, Berger LA, Böttcher LM, Päsler S, Gorges TM, O'Flaherty L, Hille C, Joosse SA, ... Simon R, et al. Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors. Cancers. 11. PMID 31212989 DOI: 10.3390/cancers11060835 |
0.01 |
|
| 2019 |
Mandelkow T, Blessin NC, Lueerss E, Pott L, Simon R, Li W, Wellge B, Debatin NF, Höflmayer D, Izbicki JR, Büscheck F, Luebke AM, Wittmer C, Jacobsen F, Lutz F, et al. Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder. Disease Markers. 2019: 2532518. PMID 31191745 DOI: 10.1155/2019/2532518 |
0.01 |
|
| 2019 |
Ritter C, Wollmann T, Bernhard P, Gunkel M, Braun DM, Lee JY, Meiners J, Simon R, Sauter G, Erfle H, Rippe K, Bartenschlager R, Rohr K. Hyperparameter optimization for image analysis: application to prostate tissue images and live cell data of virus-infected cells. International Journal of Computer Assisted Radiology and Surgery. PMID 31177423 DOI: 10.1007/s11548-019-02010-3 |
0.01 |
|
| 2019 |
Brauer DL, Woessner K, Simon R, Modena B, White A. Subcutaneous Immunotherapy Induced Local Skin Necrosis. The Journal of Allergy and Clinical Immunology. in Practice. PMID 31056450 DOI: 10.1016/j.jaip.2019.03.047 |
0.01 |
|
| 2019 |
Kloth K, Renner S, Burmester G, Steinemann D, Pabst B, Lorenz B, Simon R, Kolbe V, Hempel M, Rosenberger G. 16p13.11 microdeletion uncovers loss-of-function of a MYH11 missense variant in a patient with megacystis-microcolon-intestinal-hypoperistalsis syndrome. Clinical Genetics. PMID 31044419 DOI: 10.1111/cge.13557 |
0.01 |
|
| 2019 |
Höflmayer D, Willich C, Hube-Magg C, Simon R, Lang D, Neubauer E, Jacobsen F, Hinsch A, Luebke AM, Tsourlakis MC, Huland H, Graefen M, Haese A, Heinzer H, Minner S, et al. SNW1 is a prognostic biomarker in prostate cancer. Diagnostic Pathology. 14: 33. PMID 31043167 DOI: 10.1186/s13000-019-0810-8 |
0.01 |
|
| 2019 |
Eichenauer T, Hussein M, Hube-Magg C, Kluth M, Büscheck F, Höflmayer D, Tsourlakis MC, Steurer S, Clauditz TS, Luebke AM, Burandt E, Wilczak W, Hinsch A, Dum D, Beyer B, ... ... Simon R, et al. A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer. Oncotarget. 10: 1729-1744. PMID 30899444 DOI: 10.18632/oncotarget.26739 |
0.01 |
|
| 2019 |
Melling N, Norrenbrock S, Kluth M, Simon R, Hube-Magg C, Steurer S, Hinsch A, Burandt E, Jacobsen F, Wilczak W, Quaas A, Bockhorn M, Grupp K, Tachezy M, Izbicki J, et al. p53 overexpression is a prognosticator of poor outcome in esophageal cancer. Oncology Letters. 17: 3826-3834. PMID 30881503 DOI: 10.3892/ol.2019.10020 |
0.01 |
|
| 2019 |
Schroeder C, Grell J, Hube-Magg C, Kluth M, Lang D, Simon R, Höflmayer D, Minner S, Burandt E, Clauditz TS, Büscheck F, Jacobsen F, Huland H, Graefen M, Schlomm T, et al. Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer. Bmc Cancer. 19: 193. PMID 30823906 DOI: 10.1186/s12885-019-5390-1 |
0.01 |
|
| 2019 |
Blessin NC, Simon R, Kluth M, Fischer K, Hube-Magg C, Li W, Makrypidi-Fraune G, Wellge B, Mandelkow T, Debatin NF, Höflmayer D, Lennartz M, Sauter G, Izbicki JR, Minner S, et al. Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer. Disease Markers. 2019: 5160565. PMID 30733837 DOI: 10.1155/2019/5160565 |
0.01 |
|
| 2019 |
Kluth M, Al Kilani Z, Özden C, Hussein K, Frogh S, Möller-Koop C, Burandt E, Steurer S, Büscheck F, Jacobsen F, Luebke AM, Minner S, Tsourlakis MC, Hoeflmayer D, Wittmer C, ... ... Simon R, et al. 5q21 deletion is often heterogeneous in prostate cancer. Genes, Chromosomes & Cancer. PMID 30623509 DOI: 10.1002/gcc.22730 |
0.01 |
|
| 2018 |
Höflmayer D, Öztürk E, Schroeder C, Hube-Magg C, Blessin NC, Simon R, Lang DS, Neubauer E, Göbel C, Heinrich MC, Fraune C, Möller K, Armbrust M, Freytag M, Hinsch A, et al. High expression of class III β-tubulin in upper gastrointestinal cancer types. Oncology Letters. 16: 7139-7145. PMID 30546449 DOI: 10.3892/ol.2018.9502 |
0.01 |
|
| 2018 |
Gerhauser C, Favero F, Risch T, Simon R, Feuerbach L, Assenov Y, Heckmann D, Sidiropoulos N, Waszak SM, Hübschmann D, Urbanucci A, Girma EG, Kuryshev V, Klimczak LJ, Saini N, et al. Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories. Cancer Cell. 34: 996-1011.e8. PMID 30537516 DOI: 10.1016/J.Ccell.2018.10.016 |
0.01 |
|
| 2018 |
Göbel C, Özden C, Schroeder C, Hube-Magg C, Kluth M, Möller-Koop C, Neubauer E, Hinsch A, Jacobsen F, Simon R, Sauter G, Michl U, Pehrke D, Huland H, Graefen M, et al. Upregulation of centromere protein F is linked to aggressive prostate cancers. Cancer Management and Research. 10: 5491-5504. PMID 30519097 DOI: 10.2147/CMAR.S165630 |
0.01 |
|
| 2018 |
Li W, Blessin NC, Simon R, Kluth M, Fischer K, Hube-Magg C, Makrypidi-Fraune G, Wellge B, Mandelkow T, Debatin NF, Pott L, Höflmayer D, Lennartz M, Sauter G, Izbicki JR, et al. Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma. Bmc Cancer. 18: 1209. PMID 30514251 DOI: 10.1186/s12885-018-5111-1 |
0.01 |
|
| 2018 |
Kluth M, Volta H, Hussein M, Taskin B, Frogh S, Möller-Koop C, Büscheck F, Jacobsen F, Tsourlakis MC, Lübke AM, Hinsch A, Clauditz T, Graefen M, Heinzer H, Huland H, ... ... Simon R, et al. Deletion of 3p13 is a late event linked to progression of : fusion prostate cancer. Cancer Management and Research. 10: 5909-5917. PMID 30510458 DOI: 10.2147/CMAR.S172637 |
0.01 |
|
| 2018 |
Lange T, Oh-Hohenhorst SJ, Joosse SA, Pantel K, Hahn O, Gosau T, Dyshlovoy SA, Wellbrock J, Feldhaus S, Maar H, Gehrcke R, Kluth M, Simon R, Schlomm T, Huland H, et al. Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer. Scientific Reports. 8: 17535. PMID 30510249 DOI: 10.1038/s41598-018-35695-8 |
0.01 |
|
| 2018 |
Minner S, Lutz J, Hube-Magg C, Kluth M, Simon R, Höflmayer D, Burandt E, Tsourlakis MC, Sauter G, Büscheck F, Wilczak W, Steurer S, Schlomm T, Huland H, Graefen M, et al. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers. The Prostate. PMID 30430607 DOI: 10.1002/pros.23736 |
0.01 |
|
| 2018 |
Grupp K, Hofmann B, Kutup A, Bachmann K, Bogoevski D, Melling N, Uzunoglu FG, El Gammal AT, Koop C, Simon R, Steurer S, Krech T, Burdak-Rothkamm S, Jacobsen F, Sauter G, et al. Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome. Bmc Cancer. 18: 1106. PMID 30419865 DOI: 10.1186/s12885-018-5032-z |
0.01 |
|
| 2018 |
Bulva J, Simon RA. Clopidogrel Desensitization: Background and Recommendations for Use of a Rapid (4 Hour) Protocol. Current Vascular Pharmacology. PMID 30378498 DOI: 10.2174/1570161116666181031101930 |
0.01 |
|
| 2018 |
Brandi F, Grupp K, Hube-Magg C, Kluth M, Lang D, Minner S, Möller-Koop C, Graefen M, Heinzer H, Tsourlakis MC, Wittmer C, Jacobsen F, Huland H, Steurer S, Lebok P, ... ... Simon R, et al. High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases. Oncology Letters. 16: 6238-6244. PMID 30333886 DOI: 10.3892/ol.2018.9417 |
0.01 |
|
| 2018 |
Büscheck F, Fraune C, Simon R, Kluth M, Hube-Magg C, Möller-Koop C, Shadanpour N, Bannenberg C, Eichelberg C, Höflmayer D, Clauditz T, Wittmer C, Wilczak W, Sauter G, Fisch M, et al. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma. Urologic Oncology. PMID 30322727 DOI: 10.1016/j.urolonc.2018.08.015 |
0.01 |
|
| 2018 |
Kari V, Mansour WY, Raul SK, Baumgart SJ, Mund A, Grade M, Sirma H, Simon R, Will H, Dobbelstein M, Dikomey E, Johnsen SA. Loss of causes DNA repair defects and enhances prostate cancer therapeutic responsiveness. Embo Reports. 19. PMID 30291165 DOI: 10.15252/embr.201846783 |
0.01 |
|
| 2018 |
Berger LA, Janning M, Velthaus JL, Ben-Batalla I, Schatz S, Falk M, Iglauer P, Simon R, Cao R, Forcato C, Manaresi N, Bramlett K, Buson G, Hanssen A, Tiemann M, et al. Identification of a high-level MET amplification in CTCs and cfTNA of an ALK+ NSCLC patient developing evasive resistance to crizotinib. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30205165 DOI: 10.1016/j.jtho.2018.08.2025 |
0.01 |
|
| 2018 |
Kim J, Simon R. Calculated Decisions: Wound Closure Classification Pediatric Emergency Medicine Practice. 14: 1-3. PMID 30183415 |
0.01 |
|
| 2018 |
Heumann A, Kaya Ö, Burdelski C, Hube-Magg C, Kluth M, Lang DS, Simon R, Beyer B, Thederan I, Sauter G, Izbicki JR, Luebke AM, Hinsch A, Jacobsen F, Wittmer C, et al. Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer. Scientific Reports. 8: 12821. PMID 30127371 DOI: 10.1038/s41598-018-30975-9 |
0.01 |
|
| 2018 |
Kluth M, Scherzai S, Büschek F, Fraune C, Möller K, Höflmayer D, Minner S, Göbel C, Möller-Koop C, Hinsch A, Neubauer E, Tsourlakis MC, Sauter G, Heinzer H, Graefen M, ... ... Simon R, et al. 13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer. Genes, Chromosomes & Cancer. PMID 29923647 DOI: 10.1002/gcc.22645 |
0.01 |
|
| 2018 |
Wilczak W, Wittmer C, Clauditz T, Minner S, Steurer S, Büscheck F, Krech T, Lennartz M, Harms L, Leleu D, Ahrens M, Ingwerth S, Günther CT, Koop C, Simon R, et al. Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer. European Urology. PMID 29908878 DOI: 10.1016/j.eururo.2018.05.034 |
0.01 |
|
| 2018 |
Heinrich MC, Göbel C, Kluth M, Bernreuther C, Sauer C, Schroeder C, Möller-Koop C, Hube-Magg C, Lebok P, Burandt E, Sauter G, Simon R, Huland H, Graefen M, Heinzer H, et al. PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer. Bmc Cancer. 18: 612. PMID 29855276 DOI: 10.1186/s12885-018-4547-7 |
0.01 |
|
| 2018 |
Neubauer E, Latif M, Krause J, Heumann A, Armbrust M, Luehr C, Fraune C, Hube-Magg C, Kluth M, Möller-Koop C, Sauter G, Simon R, Beyer B, Pompe RS, Thederan I, et al. Up regulation of the steroid hormone synthesis regulator HSD3B2 is linked to early PSA recurrence in prostate cancer. Experimental and Molecular Pathology. PMID 29803408 DOI: 10.1016/j.yexmp.2018.05.006 |
0.01 |
|
| 2018 |
Savel RH, Cohen W, Borgia D, Simon RJ. The Intensive Care Unit Perspective of Becoming a Level I Trauma Center: Challenges of Strategy, Leadership, and Operations Management. Journal of Emergencies, Trauma, and Shock. 11: 65-70. PMID 29628674 DOI: 10.4103/JETS.JETS_9_17 |
0.01 |
|
| 2018 |
Savel RH, Shiloh AL, Simon RJ, Kupfer Y. Using Big Data to See the Big Picture in Sepsis. Critical Care Medicine. 46: 640-641. PMID 29538113 DOI: 10.1097/CCM.0000000000002976 |
0.01 |
|
| 2018 |
Oing C, Tennstedt P, Simon R, Volquardsen J, Borgmann K, Bokemeyer C, Petersen C, Dikomey E, Rothkamm K, Mansour WY. BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy. Cancer Letters. PMID 29526801 DOI: 10.1016/j.canlet.2018.03.007 |
0.01 |
|
| 2018 |
Hinsch A, Brolund M, Hube-Magg C, Kluth M, Simon R, Möller-Koop C, Sauter G, Steurer S, Luebke A, Angerer A, Wittmer C, Neubauer E, Göbel C, Büscheck F, Minner S, et al. Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer. World Journal of Urology. PMID 29427004 DOI: 10.1007/s00345-018-2225-7 |
0.01 |
|
| 2018 |
Heumann A, Heinemann N, Hube-Magg C, Lang DS, Grupp K, Kluth M, Minner S, Möller-Koop C, Graefen M, Heinzer H, Tsourlakis MC, Wilczak W, Wittmer C, Jacobsen F, Huland H, ... Simon R, et al. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer. Bmc Cancer. 18: 37. PMID 29304771 DOI: 10.1186/s12885-017-3956-3 |
0.01 |
|
| 2017 |
Kluth M, Jung S, Habib O, Eshagzaiy M, Heinl A, Amschler N, Masser S, Mader M, Runte F, Barow P, Frogh S, Omari J, Möller-Koop C, Hube-Magg C, Weischenfeldt J, ... ... Simon R, et al. Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer. Oncotarget. 8: 108923-108935. PMID 29312579 DOI: 10.18632/Oncotarget.22408 |
0.01 |
|
| 2017 |
Nienstedt JC, Schroeder C, Clauditz T, Simon R, Sauter G, Muenscher A, Blessmann M, Hanken H, Pflug C. EZH2 overexpression in head and neck cancer is related to lymph node metastasis. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. PMID 29285811 DOI: 10.1111/jop.12673 |
0.01 |
|
| 2017 |
Burdelski C, Jakani-Karimi N, Jacobsen F, Möller-Koop C, Minner S, Simon R, Sauter G, Steurer S, Clauditz TS, Wilczak W. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues. Oncology Reports. PMID 29115542 DOI: 10.3892/or.2017.6072 |
0.01 |
|
| 2017 |
Lotan TL, Heumann A, Rico SD, Hicks J, Lecksell K, Koop C, Sauter G, Schlomm T, Simon R. PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort. Oncotarget. 8: 65566-65576. PMID 29029453 DOI: 10.18632/oncotarget.19217 |
0.01 |
|
| 2017 |
Tsourlakis MC, Eleftheriadou A, Stender A, Weigand P, Grupp K, Hube-Magg C, Kluth M, Schroeder C, Steurer S, Hinsch A, Luebke A, Angerer A, Wittmer C, Friedrich E, Göbel C, ... ... Simon R, et al. FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy. Carcinogenesis. PMID 29029032 DOI: 10.1093/carcin/bgx105 |
0.01 |
|
| 2017 |
Person F, Wilczak W, Hube-Magg C, Burdelski C, Möller-Koop C, Simon R, Noriega M, Sauter G, Steurer S, Burdak-Rothkamm S, Jacobsen F. Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 39: 1010428317712166. PMID 29022485 DOI: 10.1177/1010428317712166 |
0.01 |
|
| 2017 |
Hopkins JF, Sabelnykova VY, Weischenfeldt J, Simon R, Aguiar JA, Alkallas R, Heisler LE, Zhang J, Watson JD, Chua MLK, Fraser M, Favero F, Lawerenz C, Plass C, Sauter G, et al. Mitochondrial mutations drive prostate cancer aggression. Nature Communications. 8: 656. PMID 28939825 DOI: 10.1038/S41467-017-00377-Y |
0.01 |
|
| 2017 |
Burdelski C, Shihada R, Hinsch A, Angerer A, Göbel C, Friedrich E, Hube-Magg C, Burdak-Rothkamm S, Kluth M, Simon R, Möller-Koop C, Sauter G, Büscheck F, Wittmer C, Clauditz TS, et al. High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer. The Prostate. PMID 28929505 DOI: 10.1002/pros.23431 |
0.01 |
|
| 2017 |
Jacobsen F, Kraft J, Schroeder C, Hube-Magg C, Kluth M, Lang DS, Simon R, Sauter G, Izbicki JR, Clauditz TS, Luebke AM, Hinsch A, Wilczak W, Wittmer C, Büscheck F, et al. Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer. Neoplasia (New York, N.Y.). 19: 707-715. PMID 28830008 DOI: 10.1016/j.neo.2017.06.003 |
0.01 |
|
| 2017 |
Lotan TL, Heumann A, Rico SD, Hicks J, Lecksell K, Koop C, Sauter G, Schlomm T, Simon R. PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort. Oncotarget. PMID 28747566 DOI: 10.18632/oncotarget.19217 |
0.01 |
|
| 2017 |
Jacobsen F, Taskin B, Melling N, Sauer C, Wittmer C, Hube-Magg C, Kluth M, Simon R, Pehrke D, Beyer B, Steuber T, Thederan I, Sauter G, Schlomm T, Wilczak W, et al. Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer. Bmc Cancer. 17: 504. PMID 28747165 DOI: 10.1186/s12885-017-3489-9 |
0.01 |
|
| 2017 |
Walters KM, Simon RA, Woessner KM, Wineinger NE, White AA. Effect of misoprostol on patients with aspirin-exacerbated respiratory disease undergoing aspirin challenge and desensitization. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 119: 71-76. PMID 28668243 DOI: 10.1016/j.anai.2017.05.003 |
0.01 |
|
| 2017 |
Nienstedt JC, Gröbe A, Clauditz T, Simon R, Muenscher A, Knecht R, Sauter G, Moebius C, Blessmann M, Heiland M, Pflug C. High level βIII-tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcome. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. PMID 28640948 DOI: 10.1111/jop.12607 |
0.01 |
|
| 2017 |
Brauer DL, Tse KY, Lin JC, Schatz MX, Simon RA. The Utility of the Reflux Symptom Index for Diagnosis of Laryngopharyngeal Reflux in an Allergy Patient Population. The Journal of Allergy and Clinical Immunology. in Practice. PMID 28606786 DOI: 10.1016/j.jaip.2017.04.039 |
0.01 |
|
| 2017 |
Waldram J, Walters K, Simon R, Woessner K, Waalen J, White A. Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: a single center study. The Journal of Allergy and Clinical Immunology. PMID 28550988 DOI: 10.1016/j.jaci.2017.05.006 |
0.01 |
|
| 2017 |
Heumann A, Kaya Ö, Burdelski C, Hube-Magg C, Kluth M, Lang DS, Simon R, Beyer B, Thederan I, Sauter G, Izbicki JR, Luebke AM, Hinsch A, Jacobsen F, Wittmer C, et al. Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer. Scientific Reports. 7: 2056. PMID 28515422 DOI: 10.1038/s41598-017-02279-x |
0.01 |
|
| 2017 |
Cook KA, Modena BD, Wineinger NE, Woessner KM, Simon RA, White AA. Use of a composite symptom score during challenge in patients with suspected aspirin-exacerbated respiratory disease. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 118: 597-602. PMID 28477789 DOI: 10.1016/j.anai.2017.02.016 |
0.01 |
|
| 2017 |
Juhnke M, Heumann A, Chirico V, Höflmayer D, Menz A, Hinsch A, Hube-Magg C, Kluth M, Lang DS, Möller-Koop C, Sauter G, Simon R, Beyer B, Pompe R, Thederan I, et al. Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2: ERG fusion. Molecular Carcinogenesis. PMID 28467610 DOI: 10.1002/mc.22670 |
0.01 |
|
| 2017 |
Burdelski C, Borcherding L, Kluth M, Hube-Magg C, Melling N, Simon R, Möller-Koop C, Weigand P, Minner S, Haese A, Michl HU, Tsourlakis MC, Jacobsen F, Hinsch A, Wittmer C, et al. Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer. Oncotarget. PMID 28415558 DOI: 10.18632/oncotarget.16357 |
0.01 |
|
| 2017 |
Steurer S, Rico SD, Simon R, Minner S, Tsourlakis MC, Krech T, Koop C, Graefen M, Heinzer H, Adam M, Huland H, Schlomm T, Sauter G, Lumiani A. High concordance of findings obtained from in-gantry transgluteal MRI- and TRUS-guided biopsy as compared to prostatectomy specimens. Bju International. PMID 28295933 DOI: 10.1111/bju.13840 |
0.01 |
|
| 2017 |
Burdelski C, Fitzner M, Hube-Magg C, Kluth M, Heumann A, Simon R, Krech T, Clauditz T, Büscheck F, Steurer S, Wittmer C, Hinsch A, Luebke AM, Jacobsen F, Minner S, et al. Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers. Neoplasia (New York, N.Y.). 19: 279-287. PMID 28282546 DOI: 10.1016/j.neo.2017.01.005 |
0.01 |
|
| 2017 |
Melling N, Rashed M, Schroeder C, Hube-Magg C, Kluth M, Lang D, Simon R, Möller-Koop C, Steurer S, Sauter G, Jacobsen F, Büscheck F, Wittmer C, Clauditz T, Krech T, et al. High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer. International Journal of Molecular Sciences. 18. PMID 28146062 DOI: 10.3390/ijms18020286 |
0.01 |
|
| 2017 |
Kluth M, Ahrary R, Hube-Magg C, Ahmed M, Volta H, Schwemin C, Steurer S, Wittmer C, Wilczak W, Burandt E, Krech T, Adam M, Michl U, Heinzer H, Salomon G, ... ... Simon R, et al. Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer. Oncotarget. 8: 3761. PMID 28143998 DOI: 10.18632/oncotarget.14557 |
0.01 |
|
| 2017 |
Hinsch A, Buchholz M, Odinga S, Borkowski C, Koop C, Izbicki JR, Wurlitzer M, Krech T, Wilczak W, Steurer S, Jacobsen F, Burandt EC, Stahl P, Simon R, Sauter G, et al. MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarrays. Journal of Mass Spectrometry : Jms. PMID 28117928 DOI: 10.1002/jms.3916 |
0.01 |
|
| 2017 |
Sauter G, Clauditz T, Steurer S, Wittmer C, Büscheck F, Krech T, Lutz F, Lennartz M, Harms L, Lawrenz L, Möller-Koop C, Simon R, Jacobsen F, Wilczak W, Minner S, et al. Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens. European Urology. PMID 28117112 DOI: 10.1016/j.eururo.2017.01.015 |
0.01 |
|
| 2016 |
Stahl PR, Hoxha E, Wiech T, Schröder C, Simon R, Stahl RA. THSD7A Expression in Human Cancer. Genes, Chromosomes & Cancer. PMID 28035718 DOI: 10.1002/gcc.22440 |
0.01 |
|
| 2016 |
Hinsch A, Chaker A, Burdelski C, Koop C, Tsourlakis MC, Steurer S, Rink M, Eichenauer TS, Wilczak W, Wittmer C, Fisch M, Simon R, Sauter G, Büschek F, Clauditz T, et al. βIII-tubulin overexpression is linked to agressive tumor features and genetic instability in urinary bladder cancer. Human Pathology. PMID 28025079 DOI: 10.1016/j.humpath.2016.11.005 |
0.01 |
|
| 2016 |
Kluth M, Amschler NN, Galal R, Möller-Koop C, Barrow P, Tsourlakis MC, Jacobsen F, Hinsch A, Wittmer C, Steurer S, Krech T, Büscheck F, Clauditz TS, Beyer B, Wilczak W, ... ... Simon R, et al. Deletion of 8p is an independent prognostic parameter in prostate cancer. Oncotarget. PMID 27880722 DOI: 10.18632/oncotarget.13425 |
0.01 |
|
| 2016 |
Kluth M, Graunke M, Möller-Koop C, Hube-Magg C, Minner S, Michl U, Graefen M, Huland H, Pompe R, Jacobsen F, Hinsch A, Wittmer C, Lebok P, Steurer S, Büscheck F, ... ... Simon R, et al. Deletion of 18q is a strong and independent prognostic feature in prostate cancer. Oncotarget. PMID 27861151 DOI: 10.18632/oncotarget.13404 |
0.01 |
|
| 2016 |
Simon RA, Woessner K, White AA. Can NSAID-Induced Urticaria Be Treated? The Journal of Allergy and Clinical Immunology. in Practice. 4: 1213-1214. PMID 27836064 DOI: 10.1016/j.jaip.2016.07.021 |
0.01 |
|
| 2016 |
Lebok P, Roming M, Kluth M, Koop C, Özden C, Taskin B, Hussein K, Lebeau A, Witzel I, Wölber L, Geist S, Paluchowski P, Wilke C, Heilenkötter U, Müller V, ... ... Simon R, et al. p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer. Oncotarget. PMID 27835607 DOI: 10.18632/oncotarget.13227 |
0.01 |
|
| 2016 |
Wilczak W, Rashed S, Hube-Magg C, Kluth M, Simon R, Büscheck F, Clauditz TS, Grupp K, Minner S, Tsourlakis MC, Koop C, Graefen M, Adam M, Haese A, Wittmer C, et al. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability, and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer. Carcinogenesis. PMID 27803051 DOI: 10.1093/carcin/bgw116 |
0.01 |
|
| 2016 |
Savel RH, Simon RJ, Kupfer Y. Unraveling the Mysterious Relationship Between Obesity and Outcomes in Patients With Sepsis. Critical Care Medicine. 44: 2104-2105. PMID 27755069 DOI: 10.1097/CCM.0000000000001916 |
0.01 |
|
| 2016 |
Gunkel M, Chung I, Wörz S, Deeg KI, Simon R, Sauter G, Jones DT, Korshunov A, Rohr K, Erfle H, Rippe K. Quantification of telomere features in tumor tissue sections by an automated 3D imaging-based workflow. Methods (San Diego, Calif.). PMID 27725304 DOI: 10.1016/j.ymeth.2016.09.014 |
0.01 |
|
| 2016 |
Waldram JD, Simon RA. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease. Immunology and Allergy Clinics of North America. 36: 693-703. PMID 27712764 DOI: 10.1016/j.iac.2016.06.006 |
0.01 |
|
| 2016 |
Kari V, Mansour WY, Raul SK, Baumgart SJ, Mund A, Grade M, Sirma H, Simon R, Will H, Dobbelstein M, Dikomey E, Johnsen SA. Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness. Embo Reports. PMID 27596623 DOI: 10.15252/embr.201642352 |
0.01 |
|
| 2016 |
Tsourlakis MC, Stender A, Quaas A, Kluth M, Wittmer C, Haese A, Graefen M, Steurer S, Simon R, Korbel J, Weischenfeldt J, Huland H, Sauter G, Schlomm T, Minner S. Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients. Bmc Cancer. 16: 641. PMID 27530104 DOI: 10.1186/S12885-016-2674-6 |
0.01 |
|
| 2016 |
Nienstedt JC, Gröbe A, Lebok P, Büscheck F, Clauditz T, Simon R, Heumann A, Sauter G, Moebius C, Münscher A, Knecht R, Blessmann M, Heiland M, Pflug C. CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer. Clinical Oral Investigations. PMID 27444451 DOI: 10.1007/s00784-016-1911-3 |
0.01 |
|
| 2016 |
Burdelski C, Dieckmann T, Heumann A, Hube-Magg C, Kluth M, Beyer B, Steuber T, Pompe R, Graefen M, Simon R, Minner S, Tsourlakis MC, Koop C, Izbicki J, Sauter G, et al. p16 upregulation is linked to poor prognosis in ERG negative prostate cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 27444279 DOI: 10.1007/s13277-016-5167-y |
0.01 |
|
| 2016 |
Lebok P, Huber J, Burandt EC, Lebeau A, Marx AH, Terracciano L, Heilenkötter U, Jänicke F, Müller V, Paluchowski P, Geist S, Wilke C, Simon R, Sauter G, Quaas A. Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer. Molecular Medicine Reports. PMID 27357606 DOI: 10.3892/mmr.2016.5430 |
0.01 |
|
| 2016 |
Militello KT, Simon RD, Mandarano AH, DiNatale A, Hennick SM, Lazatin JC, Cantatore S. 5-azacytidine induces transcriptome changes in Escherichia coli via DNA methylation-dependent and DNA methylation-independent mechanisms. Bmc Microbiology. 16: 130. PMID 27349222 DOI: 10.1186/S12866-016-0741-4 |
0.01 |
|
| 2016 |
Cook KA, Modena BD, Simon RA. Improvement in Asthma Control Using a Minimally Burdensome and Proactive Smartphone Application. The Journal of Allergy and Clinical Immunology. in Practice. PMID 27107690 DOI: 10.1016/j.jaip.2016.03.005 |
0.01 |
|
| 2016 |
Kaban JM, Stone ME, Dayama A, Safadjou S, Reddy SH, Simon R, Teperman S. Does Resident Trauma Exposure Affect Advanced Trauma Operative Management Course Experience? The American Surgeon. 82: 212-5. PMID 27099056 |
0.01 |
|
| 2016 |
Arslan A, Flax L, Fraser R, Kanter M, Simon R, Caputo ND. Twenty-four-hour packed red blood cell requirement is the strongest independent prognostic marker of mortality in ED trauma patients. The American Journal of Emergency Medicine. PMID 27066932 DOI: 10.1016/j.ajem.2016.03.036 |
0.01 |
|
| 2016 |
Ramachandran G, Tennant SM, Boyd MA, Wang JY, Tulapurkar ME, Pasetti MF, Levine MM, Simon R. Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella. Plos One. 11: e0151875. PMID 26998925 DOI: 10.1371/journal.pone.0151875 |
0.01 |
|
| 2016 |
Lebok P, Öztürk M, Heilenkötter U, Jaenicke F, Müller V, Paluchowski P, Geist S, Wilke C, Burandt E, Lebeau A, Wilczak W, Krech T, Simon R, Sauter G, Quaas A. High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer. Oncology Letters. 11: 1987-1994. PMID 26998111 DOI: 10.3892/ol.2016.4206 |
0.01 |
|
| 2016 |
Palaganas JC, Fey M, Simon R. Structured Debriefing in Simulation-Based Education. Aacn Advanced Critical Care. 27: 78-85. PMID 26909457 DOI: 10.4037/Aacnacc2016328 |
0.01 |
|
| 2016 |
Leng TD, Si HF, Li J, Yang T, Zhu M, Wang B, Simon RP, Xiong ZG. Amiloride Analogs as ASIC1a Inhibitors. Cns Neuroscience & Therapeutics. PMID 26890278 DOI: 10.1111/Cns.12524 |
0.01 |
|
| 2016 |
Obeid NR, Bryk DJ, Lee T, Hemmert KC, Frangos SG, Simon RJ, Pachter HL, Cohen SM. Fatal Falls in New York City: An Autopsy Analysis of Injury Patterns. The American Journal of Forensic Medicine and Pathology. PMID 26825256 DOI: 10.1097/PAF.0000000000000220 |
0.01 |
|
| 2016 |
Lennartz M, Minner S, Brasch S, Wittmann H, Paterna L, Angermeier K, Öztürk E, Shihada R, Ruge M, Kluth M, Koop C, Wilczak W, Krech T, Lebok P, Wittmer C, ... ... Simon R, et al. The combination of DNA ploidy status and PTEN/6q15 deletions provides strong and independent prognostic information in prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26813356 DOI: 10.1158/1078-0432.CCR-15-0635 |
0.01 |
|
| 2016 |
Melling N, Taskin B, Hube-Magg C, Kluth M, Minner S, Koop C, Grob T, Graefen M, Heinzer H, Tsourlakis MC, Izbicki J, Wittmer C, Huland H, Simon R, Wilczak W, et al. Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer. The Prostate. 76: 259-72. PMID 26764246 DOI: 10.1002/pros.23120 |
0.01 |
|
| 2016 |
Dancau AM, Simon R, Mirlacher M, Sauter G. Tissue Microarrays. Methods in Molecular Biology (Clifton, N.J.). 1381: 53-65. PMID 26667454 DOI: 10.1007/978-1-4939-3204-7_3 |
0.01 |
|
| 2016 |
Lebok P, Öztürk M, Heilenkötter U, Jaenicke F, Müller V, Paluchowski P, Geist S, Wilke C, Burandt E, Lebeau A, Wilczak W, Krech T, Simon R, Sauter G, Quaas A. High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer Oncology Letters. 11: 1987-1994. DOI: 10.3892/ol.2016.4206 |
0.01 |
|
| 2016 |
Simon RL. A response to contributors Journal of the Philosophy of Sport. 1-11. DOI: 10.1080/00948705.2015.1131128 |
0.01 |
|
| 2016 |
Simon R, Pirona A, Montanari L. New Psychoactive Substances (NPS) - New Challenges for the Addiction Care System? | Neue Psychoaktive Substanzen (NPS) - neue Anforderungen an das Suchthilfesystem? Suchttherapie. 17: 27-33. DOI: 10.1055/s-0041-111762 |
0.01 |
|
| 2016 |
Simon R, Geyer S, Subramanian J, Roychowdhury S. The Bayesian basket design for genomic variant-driven phase II trials Seminars in Oncology. 43: 13-18. DOI: 10.1053/j.seminoncol.2016.01.002 |
0.01 |
|
| 2016 |
Schneider N, Bontemps S, Motte F, Ossenkopf V, Klessen RS, Simon R, Fechtenbaum S, Herpin F, Tremblin P, Csengeri T, Myers PC, Hill T, Cunningham M, Federrath C. Understanding star formation in molecular clouds: III. Probability distribution functions of molecular lines in Cygnus X Astronomy and Astrophysics. 587. DOI: 10.1051/0004-6361/201527144 |
0.01 |
|
| 2016 |
Wiesemeyer H, Güsten R, Heyminck S, Hübers HW, Menten KM, Neufeld DA, Richter H, Simon R, Stutzki J, Winkel B, Wyrowski F. Far-infrared study of tracers of oxygen chemistry in diffuse clouds Astronomy and Astrophysics. 585. DOI: 10.1051/0004-6361/201526473 |
0.01 |
|
| 2016 |
Simon R. Prohibition, legalisation, decriminalisation: Discussing a revision of cannabis legal situation | Prohibition, legalisierung, dekriminalisierung: Diskussion einer neugestaltung des cannabisrechts Sucht. 62: 43-50. DOI: 10.1024/0939-5911.a000407 |
0.01 |
|
| 2016 |
Simon RW, DiTullio BL, Foster LA, Canacari EG, Guglielmi CL. Eliminating workplace hazards in the OR Perioperative Care and Operating Room Management. 2: 18-27. DOI: 10.1016/j.pcorm.2016.01.004 |
0.01 |
|
| 2016 |
Debastiani R, Simon R, Batchelor D, Dellagustin G, Baumbach T, Fiederle M. Synchrotron-based scanning macro-X-ray fluorescence applied to fragments of Roman mural paintings Microchemical Journal. 126: 438-445. DOI: 10.1016/J.Microc.2015.12.014 |
0.01 |
|
| 2016 |
Klobes B, Arinicheva Y, Neumeier S, Simon RE, Jafari A, Bosbach D, Hermann RP. Quadrupole splitting and Eu partial lattice dynamics in europium orthophosphate EuPO 4 Hyperfine Interactions. 237. DOI: 10.1007/s10751-016-1211-y |
0.01 |
|
| 2016 |
Senkbeil T, Mohamed T, Simon R, Batchelor D, Di Fino A, Aldred N, Clare AS, Rosenhahn A. In vivo and in situ synchrotron radiation-based μ-XRF reveals elemental distributions during the early attachment phase of barnacle larvae and juvenile barnacles Analytical and Bioanalytical Chemistry. 408: 1487-1496. DOI: 10.1007/s00216-015-9253-6 |
0.01 |
|
| 2016 |
Payer SE, Schrittwieser JH, Grischek B, Simon RC, Kroutil W. Regio- and Stereoselective Biocatalytic Monoamination of a Triketone Enables Asymmetric Synthesis of Both Enantiomers of the Pyrrolizidine Alkaloid Xenovenine Employing Transaminases Advanced Synthesis and Catalysis. 358: 444-451. DOI: 10.1002/adsc.201500781 |
0.01 |
|
| 2016 |
Blaze CA, Faissler D, Schneider B, Maranda L, Barton B, Simon RF, Dodman NH. The effect of acepromazine on electroencephalographic activity in normal sedated dogs International Journal of Applied Research in Veterinary Medicine. 14: 19-29. |
0.01 |
|
| 2015 |
Simon RP, Robaa D, Alhalabi Z, Sippl W, Jung M. KATching-up on Small Molecule Modulators of Lysine Acetyltransferases. Journal of Medicinal Chemistry. PMID 26701186 DOI: 10.1021/Acs.Jmedchem.5B01502 |
0.01 |
|
| 2015 |
Friedrich C, von Bueren AO, Kolevatova L, Bernreuther C, Grob T, Sepulveda-Falla D, van den Boom L, Westphal M, Simon R, Glatzel M. Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. PMID 26686534 DOI: 10.1007/S00381-015-2981-2 |
0.01 |
|
| 2015 |
Kluth M, Meyer D, Krohn A, Freudenthaler F, Bauer M, Salomon G, Heinzer H, Michl U, Steurer S, Simon R, Sauter G, Schlomm T, Minner S. Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancer. Oncotarget. PMID 26684029 DOI: 10.18632/oncotarget.6597 |
0.01 |
|
| 2015 |
Lebok P, Kopperschmidt V, Kluth M, Hube-Magg C, Özden C, B T, Hussein K, Mittenzwei A, Lebeau A, Witzel I, Wölber L, Mahner S, Jänicke F, Geist S, Paluchowski P, ... ... Simon R, et al. Partial PTEN deletion is linked to poor prognosis in breast cancer. Bmc Cancer. 15: 963. PMID 26672755 DOI: 10.1186/s12885-015-1770-3 |
0.01 |
|
| 2015 |
Pust A, Kylies D, Hube-Magg C, Kluth M, Minner S, Koop C, Grob T, Graefen M, Salomon G, Tsourlakis MC, Izbicki J, Wittmer C, Huland H, Simon R, Wilczak W, et al. Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence. Human Pathology. PMID 26614400 DOI: 10.1016/j.humpath.2015.09.026 |
0.01 |
|
| 2015 |
Lih CJ, Sims DJ, Harrington RD, Polley EC, Zhao Y, Mehaffey MG, Forbes TD, Das B, Walsh WD, Datta V, Harper KN, Bouk CH, Rubinstein LV, Simon RM, Conley BA, et al. Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial. The Journal of Molecular Diagnostics : Jmd. PMID 26602013 DOI: 10.1016/J.Jmoldx.2015.07.006 |
0.01 |
|
| 2015 |
Curtis B, Grassel C, Laufer R, Sears K, Pasetti MF, Barry EM, Simon R. Simple method for purification of enterotoxigenic E. coli fimbriae. Protein Expression and Purification. PMID 26581778 DOI: 10.1016/J.Pep.2015.11.007 |
0.01 |
|
| 2015 |
Abboud P, Patel S, Mirkin L, Simon R. 1213: BORDETELLA PERTUSSIS BACTEREMIA ASSOCIATED WITH FULMINANT PERTUSSIS PNEUMONIA. Critical Care Medicine. 43: 305. PMID 26570874 DOI: 10.1097/01.ccm.0000475044.60123.e0 |
0.01 |
|
| 2015 |
McPhee D, Priovolos S, Lueders M, Kigongo-Mwesezi S, Simon R. 886: TAKE OUT THE FOLEY!! MINIMIZING INDWELLING URETHRAL CATHETERS AFTER ACUTE SPINAL CORD INJURY. Critical Care Medicine. 43: 223. PMID 26570547 DOI: 10.1097/01.ccm.0000474714.90004.35 |
0.01 |
|
| 2015 |
Goicoechea JR, Teyssier D, Etxaluze M, Goldsmith PF, Ossenkopf V, Gerin M, Bergin EA, Black JH, Cernicharo J, Cuadrado S, Encrenaz P, Falgarone E, Fuente A, Hacar A, Lis DC, ... ... Simon R, et al. VELOCITY-RESOLVED [C ii] EMISSION AND [C ii]/FIR MAPPING ALONG ORION WITH HERSCHEL (.) The Astrophysical Journal. 812. PMID 26568638 DOI: 10.1088/0004-637X/812/1/75 |
0.01 |
|
| 2015 |
von Loga K, Kohlhaussen J, Burkhardt L, Simon R, Steurer S, Burdak-Rothkamm S, Jacobsen F, Sauter G, Krech T. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma. Plos One. 10: e0141867. PMID 26555375 DOI: 10.1371/journal.pone.0141867 |
0.01 |
|
| 2015 |
Sauter G, Steurer S, Clauditz TS, Krech T, Wittmer C, Lutz F, Lennartz M, Janssen T, Hakimi N, Simon R, von Petersdorff-Campen M, Jacobsen F, von Loga K, Wilczak W, Minner S, et al. Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens. European Urology. PMID 26542947 DOI: 10.1016/j.eururo.2015.10.029 |
0.01 |
|
| 2015 |
Chwiej J, Patulska A, Skoczen A, Janeczko K, Ciarach M, Simon R, Setkowicz Z. Elemental changes in the hippocampal formation following two different formulas of ketogenic diet: an X-ray fluorescence microscopy study. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. PMID 26537249 DOI: 10.1007/s00775-015-1306-y |
0.01 |
|
| 2015 |
Militello KT, Chang MM, Simon RD, Lazatin JC. Blue genes: An integrative laboratory to differentiate genetic transformation from gene mutation for underclassmen. Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology. PMID 26525488 DOI: 10.1002/Bmb.20923 |
0.01 |
|
| 2015 |
Budhiraja R, Kushida CA, Nichols DA, Walsh JK, Simon RD, Gottlieb DJ, Quan SF. Impact of Randomization, Clinic Visits, and Medical and Psychiatric Cormorbidities on Continuous Positive Airway Pressure Adherence in Obstructive Sleep Apnea. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. PMID 26518698 DOI: 10.5664/Jcsm.5578 |
0.01 |
|
| 2015 |
Simon R, Dresselhaus T. Peptides take centre stage in plant signaling. Preface. Journal of Experimental Botany. 66: 5135-8. PMID 26473197 |
0.01 |
|
| 2015 |
Kandalaft PL, Simon RA, Isacson C, Gown AM. Comparative Sensitivities and Specificities of Antibodies to Breast Markers GCDFP-15, Mammaglobin A, and Different Clones of Antibodies to GATA-3: A Study of 338 Tumors Using Whole Sections. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. PMID 26447897 DOI: 10.1097/PAI.0000000000000237 |
0.01 |
|
| 2015 |
Valooran GJ, Nair SK, Chandrasekharan K, Simon R, Dominic C. del Nido cardioplegia in adult cardiac surgery - scopes and concerns. Perfusion. PMID 26445810 DOI: 10.1177/0267659115608936 |
0.01 |
|
| 2015 |
Mounteney J, Griffiths P, Sedefov R, Noor A, Vicente J, Simon R. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015. Addiction (Abingdon, England). PMID 26419329 DOI: 10.1111/add.13056 |
0.01 |
|
| 2015 |
Melling N, Thomsen E, Tsourlakis MC, Kluth M, Hube-Magg C, Minner S, Koop C, Graefen M, Heinzer H, Wittmer C, Sauter G, Wilczak W, Huland H, Simon R, Schlomm T, et al. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters. Carcinogenesis. 36: 1333-40. PMID 26392259 DOI: 10.1093/carcin/bgv137 |
0.01 |
|
| 2015 |
Burdelski C, Kleinhans S, Kluth M, Hube-Magg C, Minner S, Koop C, Graefen M, Heinzer H, Tsourlakis MC, Wilczak W, Marx A, Sauter G, Wittmer C, Huland H, Simon R, et al. Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers. International Journal of Cancer. Journal International Du Cancer. PMID 26383228 DOI: 10.1002/ijc.29860 |
0.01 |
|
| 2015 |
Simon RE, Pearson SD, Hur C, Chung RT. Tackling the hepatitis C cost problem: A test case for tomorrow's cures. Hepatology (Baltimore, Md.). 62: 1334-6. PMID 26359645 DOI: 10.1002/hep.28157 |
0.01 |
|
| 2015 |
Riethdorf S, Frey S, Santjer S, Stoupiec M, Otto B, Riethdorf L, Koop C, Wilczak W, Simon R, Sauter G, Pantel K, Assmann V. Diverse expression patterns of the EMT suppressor grainyhead-like 2 (GRHL2) in normal and tumour tissues. International Journal of Cancer. Journal International Du Cancer. PMID 26355710 DOI: 10.1002/ijc.29841 |
0.01 |
|
| 2015 |
Tennant SM, Schmidlein P, Simon R, Pasetti MF, Galen JE, Levine MM. Refined live attenuated Salmonella Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice. Infection and Immunity. PMID 26351285 DOI: 10.1128/IAI.00924-15 |
0.01 |
|
| 2015 |
Fischer S, Lin D, Simon RM, Howard L, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ, Vidal AC. Pathologic gleason 8-10: do all men do poorly? results from the search database. Bju International. PMID 26351095 DOI: 10.1111/bju.13319 |
0.01 |
|
| 2015 |
Melling N, Grimm N, Simon R, Stahl P, Bokemeyer C, Terracciano L, Sauter G, Izbicki JR, Marx AH. Loss of H2Bub1 Expression is Linked to Poor Prognosis in Nodal Negative Colorectal Cancers. Pathology Oncology Research : Por. PMID 26347467 DOI: 10.1007/s12253-015-9977-9 |
0.01 |
|
| 2015 |
Gross MS, Phillips EA, Balen A, Eid JF, Yang C, Simon R, Martinez D, Carrion R, Perito P, Levine L, Greenfield J, Munarriz R. The Malleable Implant Salvage Technique: Infection Outcomes After Mulcahy Salvage Procedure and Replacement of Infected IPP with Malleable Prosthesis. The Journal of Urology. PMID 26343986 DOI: 10.1016/j.juro.2015.08.091 |
0.01 |
|
| 2015 |
Hanke T, Melling N, Simon R, Sauter G, Bokemeyer C, Lebok P, Terracciano LM, Izbicki JR, Marx AH. High intratumoral FOXP3(+) T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer. International Journal of Clinical and Experimental Pathology. 8: 8227-35. PMID 26339391 |
0.01 |
|
| 2015 |
Schwartz J, Simon RD. Sleep extension improves serving accuracy: A study with college varsity tennis players. Physiology & Behavior. 151: 541-4. PMID 26325012 DOI: 10.1016/j.physbeh.2015.08.035 |
0.01 |
|
| 2015 |
Kluth M, Ahrary R, Hube-Magg C, Ahmed M, Volta H, Schwemin C, Steurer S, Wittmer C, Wilczak W, Burandt E, Krech T, Adam M, Michl U, Heinzer H, Salomon G, ... ... Simon R, et al. Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer. Oncotarget. 6: 27966-79. PMID 26293672 DOI: 10.18632/oncotarget.4626 |
0.01 |
|
| 2015 |
Melling N, Kowitz CM, Simon R, Bokemeyer C, Terracciano L, Sauter G, Izbicki JR, Marx AH. High Ki67 expression is an independent good prognostic marker in colorectal cancer. Journal of Clinical Pathology. PMID 26281861 DOI: 10.1136/jclinpath-2015-202985 |
0.01 |
|
| 2015 |
Melling N, Simon R, Izbicki JR, Terracciano LM, Bokemeyer C, Sauter G, Marx AH. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization. International Journal of Clinical and Experimental Pathology. 8: 7009-15. PMID 26261591 |
0.01 |
|
| 2015 |
Somssich M, Ma Q, Weidtkamp-Peters S, Stahl Y, Felekyan S, Bleckmann A, Seidel CA, Simon R. Real-time dynamics of peptide ligand-dependent receptor complex formation in planta. Science Signaling. 8: ra76. PMID 26243190 DOI: 10.1126/scisignal.aab0598 |
0.01 |
|
| 2015 |
Melling N, Harutyunyan L, Hube-Magg C, Kluth M, Simon R, Lebok P, Minner S, Tsourlakis MC, Koop C, Graefen M, Adam M, Haese A, Wittmer C, Steurer S, Izbicki J, et al. High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer. Plos One. 10: e0134614. PMID 26230842 DOI: 10.1371/journal.pone.0134614 |
0.01 |
|
| 2015 |
Busto E, Simon RC, Kroutil W. Vinylation of Unprotected Phenols Using a Biocatalytic System. Angewandte Chemie (International Ed. in English). 54: 10899-902. PMID 26227171 DOI: 10.1002/anie.201505696 |
0.01 |
|
| 2015 |
Melling N, Muth J, Simon R, Bokemeyer C, Terracciano L, Sauter G, Izbicki JR, Marx AH. Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer. Diagnostic Pathology. 10: 125. PMID 26208856 DOI: 10.1186/s13000-015-0360-7 |
0.01 |
|
| 2015 |
Rougemont B, Simon R, Carrière R, Biarc J, Fonbonne C, Salvador A, Huillet C, Berard Y, Adam O, Manin C, Lemoine J. Absolute quantification of dengue virus serotype 4 chimera vaccine candidate in Vero cell culture by targeted mass spectrometry. Proteomics. 15: 3320-30. PMID 26205729 DOI: 10.1002/pmic.201500101 |
0.01 |
|
| 2015 |
Burdelski C, Menan D, Tsourlakis MC, Kluth M, Hube-Magg C, Melling N, Minner S, Koop C, Graefen M, Heinzer H, Wittmer C, Sauter G, Simon R, Schlomm T, Steurer S, et al. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion. Bmc Cancer. 15: 538. PMID 26202067 DOI: 10.1186/s12885-015-1555-8 |
0.01 |
|
| 2015 |
Richter N, Simon RC, Lechner H, Kroutil W, Ward JM, Hailes HC. ω-Transaminases for the amination of functionalised cyclic ketones. Organic & Biomolecular Chemistry. 13: 8843-51. PMID 26194788 DOI: 10.1039/c5ob01204j |
0.01 |
|
| 2015 |
Zargar-Shoshtari K, Kim T, Simon R, Lin HY, Yue B, Sharma P, Spiess PE, Poch MA, Pow Sang J, Sexton WJ. Surveillance Following Nephron-Sparing Surgery: An Assessment of Recurrence Patterns and Surveillance Costs. Urology. PMID 26187013 DOI: 10.1016/j.urology.2015.05.013 |
0.01 |
|
| 2015 |
Wiegreffe C, Simon R, Peschkes K, Kling C, Strehle M, Cheng J, Srivatsa S, Liu P, Jenkins NA, Copeland NG, Tarabykin V, Britsch S. Bcl11a (Ctip1) Controls Migration of Cortical Projection Neurons through Regulation of Sema3c. Neuron. 87: 311-25. PMID 26182416 DOI: 10.1016/J.Neuron.2015.06.023 |
0.01 |
|
| 2015 |
Schöner MG, Schöner CR, Simon R, Grafe TU, Puechmaille SJ, Ji LL, Kerth G. Bats Are Acoustically Attracted to Mutualistic Carnivorous Plants. Current Biology : Cb. 25: 1911-6. PMID 26166777 DOI: 10.1016/j.cub.2015.05.054 |
0.01 |
|
| 2015 |
Tsourlakis MC, Klein F, Kluth M, Quaas A, Graefen M, Haese A, Simon R, Sauter G, Schlomm T, Minner S. PSMA expression is highly homogenous in primary prostate cancer. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 23: 449-55. PMID 26153794 DOI: 10.1097/PAI.0000000000000110 |
0.01 |
|
| 2015 |
Czyzewicz N, Wildhagen M, Cattaneo P, Stahl Y, Pinto KG, Aalen RB, Butenko MA, Simon R, Hardtke CS, De Smet I. Antagonistic peptide technology for functional dissection of CLE peptides revisited. Journal of Experimental Botany. 66: 5367-74. PMID 26136270 DOI: 10.1093/jxb/erv284 |
0.01 |
|
| 2015 |
Strang J, Groshkova T, Uchtenhagen A, van den Brink W, Haasen C, Schechter MT, Lintzeris N, Bell J, Pirona A, Oviedo-Joekes E, Simon R, Metrebian N. Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction†. The British Journal of Psychiatry : the Journal of Mental Science. 207: 5-14. PMID 26135571 DOI: 10.1192/bjp.bp.114.149195 |
0.01 |
|
| 2015 |
Grupp K, Roettger L, Kluth M, Hube-Magg C, Simon R, Lebok P, Minner S, Tsourlakis MC, Koop C, Graefen M, Adam M, Haese A, Wittmer C, Sauter G, Wilczak W, et al. Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion. Oncology Reports. 34: 1211-20. PMID 26134445 DOI: 10.3892/or.2015.4080 |
0.01 |
|
| 2015 |
Simon R. Sensitivity, Specificity, PPV, and NPV for Predictive Biomarkers. Journal of the National Cancer Institute. 107. PMID 26109105 DOI: 10.1093/jnci/djv153 |
0.01 |
|
| 2015 |
Simon R, Engström M. The default mode network as a biomarker for monitoring the therapeutic effects of meditation. Frontiers in Psychology. 6: 776. PMID 26106351 DOI: 10.3389/fpsyg.2015.00776 |
0.01 |
|
| 2015 |
Butenko MA, Simon R. Beyond the meristems: similarities in the CLAVATA3 and INFLORESCENCE DEFICIENT IN ABSCISSION peptide mediated signalling pathways. Journal of Experimental Botany. 66: 5195-203. PMID 26105996 DOI: 10.1093/jxb/erv310 |
0.01 |
|
| 2015 |
Burdelski C, Bujupi E, Tsourlakis MC, Hube-Magg C, Kluth M, Melling N, Lebok P, Minner S, Koop C, Graefen M, Heinzer H, Wittmer C, Sauter G, Wilczak W, Simon R, et al. Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers. Plos One. 10: e0128525. PMID 26030748 DOI: 10.1371/journal.pone.0128525 |
0.01 |
|
| 2015 |
Meller R, Pearson A, Simon RP. Dynamic changes in DNA methylation in ischemic tolerance. Frontiers in Neurology. 6: 102. PMID 26029158 DOI: 10.3389/fneur.2015.00102 |
0.01 |
|
| 2015 |
Caputo ND, Kanter M, Fraser R, Simon R. Comparing biomarkers of traumatic shock: the utility of anion gap, base excess, and serum lactate in the ED. The American Journal of Emergency Medicine. 33: 1134-9. PMID 26027886 DOI: 10.1016/j.ajem.2015.04.085 |
0.01 |
|
| 2015 |
Stahl PR, Schnellert J, Koop C, Simon R, Marx A, Izbicki JR, Sauter G, Quaas A. Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue Microarrays. Pathology Oncology Research : Por. 21: 1183-9. PMID 26026893 DOI: 10.1007/s12253-015-9953-4 |
0.01 |
|
| 2015 |
Sim V, Kao LS, Jacobson J, Frangos S, Brundage S, Wilson CT, Simon R, Glass NE, Pachter HL, Todd SR. Can old dogs learn new "transfusion requirements in critical care": a survey of packed red blood cell transfusion practices among members of The American Association for the Surgery of Trauma. American Journal of Surgery. 210: 45-51. PMID 26025750 DOI: 10.1016/j.amjsurg.2014.08.024 |
0.01 |
|
| 2015 |
Richards S, Wink RH, Simon R. Mathematical modelling of WOX5- and CLE40-mediated columella stem cell homeostasis in Arabidopsis. Journal of Experimental Botany. 66: 5375-84. PMID 26019259 DOI: 10.1093/jxb/erv257 |
0.01 |
|
| 2015 |
Boyer F, Simon R. Asymmetric cell divisions constructing Arabidopsis stem cell niches: the emerging role of protein phosphatases. Plant Biology (Stuttgart, Germany). 17: 935-45. PMID 26012742 DOI: 10.1111/plb.12352 |
0.01 |
|
| 2015 |
Simon RM, Howard LE, Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Vidal AC. Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted? Bju International. PMID 26010251 DOI: 10.1111/bju.13182 |
0.01 |
|
| 2015 |
Kluth M, Runte F, Barow P, Omari J, Abdelaziz ZM, Paustian L, Steurer S, Christina Tsourlakis M, Fisch M, Graefen M, Tennstedt P, Huland H, Michl U, Minner S, Sauter G, ... Simon R, et al. Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer. International Journal of Cancer. Journal International Du Cancer. 137: 2354-63. PMID 26009879 DOI: 10.1002/ijc.29613 |
0.01 |
|
| 2015 |
Mandrekar SJ, Dahlberg SE, Simon R. Improving Clinical Trial Efficiency: Thinking outside the Box. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. 35: e141-7. PMID 25993165 DOI: 10.14694/EdBook_AM.2015.35.e141 |
0.01 |
|
| 2015 |
Chwiej J, Skoczen A, Matusiak K, Janeczko K, Patulska A, Sandt C, Simon R, Ciarach M, Setkowicz Z. The influence of the ketogenic diet on the elemental and biochemical compositions of the hippocampal formation. Epilepsy & Behavior : E&B. 49: 40-6. PMID 25986320 DOI: 10.1016/j.yebeh.2015.04.042 |
0.01 |
|
| 2015 |
Lebok P, Mittenzwei A, Kluth M, Özden C, Taskin B, Hussein K, Möller K, Hartmann A, Lebeau A, Witzel I, Mahner S, Wölber L, Jänicke F, Geist S, Paluchowski P, ... ... Simon R, et al. 8p deletion is strongly linked to poor prognosis in breast cancer. Cancer Biology & Therapy. 1-8. PMID 25961141 DOI: 10.1080/15384047.2015.1046025 |
0.01 |
|
| 2015 |
Meller R, Simon RP. A critical review of mechanisms regulating remote preconditioning-induced brain protection. Journal of Applied Physiology (Bethesda, Md. : 1985). jap.00169.2015. PMID 25953834 DOI: 10.1152/japplphysiol.00169.2015 |
0.01 |
|
| 2015 |
Holzer AK, Hiebler K, Mutti FG, Simon RC, Lauterbach L, Lenz O, Kroutil W. Asymmetric Biocatalytic Amination of Ketones at the Expense of NH3 and Molecular Hydrogen. Organic Letters. 17: 2431-3. PMID 25946312 DOI: 10.1021/acs.orglett.5b01154 |
0.01 |
|
| 2015 |
Simon RA, Dazy KM, Waldram JD. Aspirin-exacerbated respiratory disease: characteristics and management strategies. Expert Review of Clinical Immunology. 11: 805-17. PMID 25936612 DOI: 10.1586/1744666X.2015.1039940 |
0.01 |
|
| 2015 |
Pesch M, Schultheiß I, Klopffleisch K, Uhrig JF, Koegl M, Clemen CS, Simon R, Weidtkamp-Peters S, Hülskamp M. TRANSPARENT TESTA GLABRA1 and GLABRA1 Compete for Binding to GLABRA3 in Arabidopsis. Plant Physiology. 168: 584-97. PMID 25926482 DOI: 10.1104/pp.15.00328 |
0.01 |
|
| 2015 |
Burdelski C, Reiswich V, Hube-Magg C, Kluth M, Minner S, Koop C, Graefen M, Heinzer H, Tsourlakis MC, Wittmer C, Huland H, Simon R, Schlomm T, Sauter G, Steurer S. Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 3471-9. PMID 25925890 DOI: 10.1158/1078-0432.CCR-14-0620 |
0.01 |
|
| 2015 |
Castañeda-Álvarez NP, de Haan S, Juárez H, Khoury CK, Achicanoy HA, Sosa CC, Bernau V, Salas A, Heider B, Simon R, Maxted N, Spooner DM. Ex situ conservation priorities for the wild relatives of potato (solanum L. Section petota). Plos One. 10: e0122599. PMID 25923711 DOI: 10.1371/journal.pone.0122599 |
0.01 |
|
| 2015 |
Melling N, Simon R, Mirlacher M, Izbicki JR, Stahl P, Terracciano LM, Bokemeyer C, Sauter G, Marx AH. Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancer. Histopathology. PMID 25922889 DOI: 10.1111/his.12726 |
0.01 |
|
| 2015 |
Biarc J, Simon R, Fonbonne C, Léonard JF, Gautier JC, Pasquier O, Lemoine J, Salvador A. Absolute quantification of podocalyxin, a potential biomarker of glomerular injury in human urine, by liquid chromatography-mass spectrometry. Journal of Chromatography. A. 1397: 81-5. PMID 25920963 DOI: 10.1016/j.chroma.2015.04.003 |
0.01 |
|
| 2015 |
Smedley D, Haider S, Durinck S, Pandini L, Provero P, Allen J, Arnaiz O, Awedh MH, Baldock R, Barbiera G, Bardou P, Beck T, Blake A, Bonierbale M, Brookes AJ, ... ... Simon R, et al. The BioMart community portal: an innovative alternative to large, centralized data repositories. Nucleic Acids Research. 43: W589-98. PMID 25897122 DOI: 10.1093/Nar/Gkv350 |
0.01 |
|
| 2015 |
Tsourlakis MC, Khosrawi P, Weigand P, Kluth M, Hube-Magg C, Minner S, Koop C, Graefen M, Heinzer H, Wittmer C, Sauter G, Krech T, Wilczak W, Huland H, Simon R, et al. VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy. International Journal of Molecular Sciences. 16: 8591-606. PMID 25894226 DOI: 10.3390/ijms16048591 |
0.01 |
|
| 2015 |
Venkataramanappa S, Simon R, Britsch S. Ex utero electroporation and organotypic slice culture of mouse hippocampal tissue. Journal of Visualized Experiments : Jove. PMID 25866930 DOI: 10.3791/52550 |
0.01 |
|
| 2015 |
Zhao Y, Polley EC, Li MC, Lih CJ, Palmisano A, Sims DJ, Rubinstein LV, Conley BA, Chen AP, Williams PM, Kummar S, Doroshow JH, Simon RM. GeneMed: An Informatics Hub for the Coordination of Next-Generation Sequencing Studies that Support Precision Oncology Clinical Trials. Cancer Informatics. 14: 45-55. PMID 25861217 DOI: 10.4137/Cin.S17282 |
0.01 |
|
| 2015 |
Carmody LA, Zhao J, Kalikin LM, LeBar W, Simon RH, Venkataraman A, Schmidt TM, Abdo Z, Schloss PD, LiPuma JJ. The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation. Microbiome. 3: 12. PMID 25834733 DOI: 10.1186/S40168-015-0074-9 |
0.01 |
|
| 2015 |
Zabalza CV, Adam M, Burdelski C, Wilczak W, Wittmer C, Kraft S, Krech T, Steurer S, Koop C, Hube-Magg C, Graefen M, Heinzer H, Minner S, Simon R, Sauter G, et al. HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy. Oncotarget. 6: 12822-34. PMID 25825985 |
0.01 |
|
| 2015 |
Reynolds JP, Miller-Delaney SF, Jimenez-Mateos EM, Sano T, McKiernan RC, Simon RP, Henshall DC. Transcriptional Response of Polycomb Group Genes to Status Epilepticus in Mice is Modified by Prior Exposure to Epileptic Preconditioning. Frontiers in Neurology. 6: 46. PMID 25806020 DOI: 10.3389/fneur.2015.00046 |
0.01 |
|
| 2015 |
Summersgill A, Kanter M, Fraser RM, Caputo ND, Simon R. Determining the utility of metabolic acidosis for trauma patients in the emergency department. The Journal of Emergency Medicine. 48: 693-8. PMID 25802159 DOI: 10.1016/j.jemermed.2014.12.081 |
0.01 |
|
| 2015 |
Simon RM, Howard L, Zapata D, Frank J, Freedland SJ, Vidal AC. The association of exercise with both erectile and sexual function in black and white men. The Journal of Sexual Medicine. 12: 1202-10. PMID 25801073 DOI: 10.1111/jsm.12869 |
0.01 |
|
| 2015 |
Burdelski C, Ruge OM, Melling N, Koop C, Simon R, Steurer S, Sauter G, Kluth M, Hube-Magg C, Minner S, Wittmer C, Wilczak W, Hinsch A, Lebok P, Izbicki JR, et al. HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer. Experimental and Molecular Pathology. 98: 419-26. PMID 25794974 DOI: 10.1016/j.yexmp.2015.03.024 |
0.01 |
|
| 2015 |
Bloss CS, Zeeland AA, Topol SE, Darst BF, Boeldt DL, Erikson GA, Bethel KJ, Bjork RL, Friedman JR, Hwynn N, Patay BA, Pockros PJ, Scott ER, Simon RA, Williams GW, et al. A genome sequencing program for novel undiagnosed diseases. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 25790160 DOI: 10.1038/Gim.2015.21 |
0.01 |
|
| 2015 |
Burdelski C, Strauss C, Tsourlakis MC, Kluth M, Hube-Magg C, Melling N, Lebok P, Minner S, Koop C, Graefen M, Heinzer H, Wittmer C, Krech T, Sauter G, Wilczak W, ... Simon R, et al. Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer. Oncotarget. 6: 8377-87. PMID 25762627 |
0.01 |
|
| 2015 |
Simon RA, Quddus MR, Lawrence WD, Sung CJ. Pathology of endometrial ablation failures: a clinicopathologic study of 164 cases. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 34: 245-52. PMID 25760902 DOI: 10.1097/PGP.0000000000000147 |
0.01 |
|
| 2015 |
Walton Diaz A, Shakir NA, George AK, Rais-Bahrami S, Turkbey B, Rothwax JT, Stamatakis L, Hong CW, Siddiqui MM, Okoro C, Raskolnikov D, Su D, Shih J, Han H, Parnes HL, ... ... Simon RM, et al. Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance. Urologic Oncology. 33: 202.e1-7. PMID 25754621 DOI: 10.1016/j.urolonc.2015.01.023 |
0.01 |
|
| 2015 |
Alter SJ, Bennett JS, Koranyi K, Kreppel A, Simon R. Common childhood viral infections. Current Problems in Pediatric and Adolescent Health Care. 45: 21-53. PMID 25703483 DOI: 10.1016/j.cppeds.2014.12.001 |
0.01 |
|
| 2015 |
Burdelski C, Barreau Y, Simon R, Hube-Magg C, Minner S, Koop C, Graefen M, Heinzer H, Sauter G, Wittmer C, Steurer S, Adam M, Huland H, Schlomm T, Tsourlakis MC, et al. Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers. Human Pathology. 46: 514-23. PMID 25701228 DOI: 10.1016/j.humpath.2014.06.006 |
0.01 |
|
| 2015 |
Simon RD. Weighing in on a heavy subject. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 11: 195-6. PMID 25700876 DOI: 10.5664/jcsm.4522 |
0.01 |
|
| 2015 |
Simon R, Blumenthal GM, Rothenberg ML, Sommer J, Roberts SA, Armstrong DK, LaVange LM, Pazdur R. The role of nonrandomized trials in the evaluation of oncology drugs. Clinical Pharmacology and Therapeutics. 97: 502-7. PMID 25676488 DOI: 10.1002/cpt.86 |
0.01 |
|
| 2015 |
Kummar S, Williams PM, Lih CJ, Polley EC, Chen AP, Rubinstein LV, Zhao Y, Simon RM, Conley BA, Doroshow JH. Application of molecular profiling in clinical trials for advanced metastatic cancers. Journal of the National Cancer Institute. 107. PMID 25663694 DOI: 10.1093/Jnci/Djv003 |
0.01 |
|
| 2015 |
Simon RA, Dazy KM, Waldram JD. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD). Current Allergy and Asthma Reports. 15: 508. PMID 25663486 DOI: 10.1007/s11882-014-0508-7 |
0.01 |
|
| 2015 |
Stoffel RP, Deringer VL, Simon RE, Hermann RP, Dronskowski R. A density-functional study on the electronic and vibrational properties of layered antimony telluride. Journal of Physics. Condensed Matter : An Institute of Physics Journal. 27: 085402. PMID 25662735 DOI: 10.1088/0953-8984/27/8/085402 |
0.01 |
|
| 2015 |
Stahl P, Seeschaaf C, Lebok P, Kutup A, Bockhorn M, Izbicki JR, Bokemeyer C, Simon R, Sauter G, Marx AH. Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer. Bmc Gastroenterology. 15: 7. PMID 25649416 DOI: 10.1186/s12876-015-0231-4 |
0.01 |
|
| 2015 |
Thewes V, Simon R, Schroeter P, Schlotter M, Anzeneder T, Büttner R, Benes V, Sauter G, Burwinkel B, Nicholson RI, Sinn HP, Schneeweiss A, Deuschle U, Zapatka M, Heck S, et al. Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer. Cancer Research. 75: 720-31. PMID 25643697 DOI: 10.1158/0008-5472.CAN-14-0652 |
0.01 |
|
| 2015 |
Siddiqui MM, Truong H, Rais-Bahrami S, Stamatakis L, Logan J, Walton-Diaz A, Turkbey B, Choyke PL, Wood BJ, Simon RM, Pinto PA. Clinical implications of a multiparametric magnetic resonance imaging based nomogram applied to prostate cancer active surveillance. The Journal of Urology. 193: 1943-9. PMID 25633923 DOI: 10.1016/j.juro.2015.01.088 |
0.01 |
|
| 2015 |
Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL, Linehan WM, Merino MJ, Simon RM, Choyke PL, Wood BJ, Pinto PA. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. Jama. 313: 390-7. PMID 25626035 DOI: 10.1001/Jama.2014.17942 |
0.01 |
|
| 2015 |
Kluth M, Galal R, Krohn A, Weischenfeldt J, Tsourlakis C, Paustian L, Ahrary R, Ahmed M, Scherzai S, Meyer A, Sirma H, Korbel J, Sauter G, Schlomm T, Simon R, et al. Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer. International Journal of Oncology. 46: 1637-42. PMID 25625310 DOI: 10.3892/Ijo.2015.2855 |
0.01 |
|
| 2015 |
Scott DR, Simon RA. Supraesophageal Reflux: Correlation of Position and Occurrence of Acid Reflux-Effect of Head-of-Bed Elevation on Supine Reflux. The Journal of Allergy and Clinical Immunology. in Practice. 3: 356-61. PMID 25609349 DOI: 10.1016/j.jaip.2014.11.019 |
0.01 |
|
| 2015 |
Ta V, Simon R. State of the Art: Medical treatment of aspirin exacerbated respiratory disease (AERD). American Journal of Rhinology & Allergy. 29: 41-3. PMID 25590318 DOI: 10.2500/ajra.2015.29.4114 |
0.01 |
|
| 2015 |
Kummar S, Oza AM, Fleming GF, Sullivan DM, Gandara DR, Naughton MJ, Villalona-Calero MA, Morgan RJ, Szabo PM, Youn A, Chen AP, Ji J, Allen DE, Lih CJ, Mehaffey MG, ... ... Simon RM, et al. Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1574-82. PMID 25589624 DOI: 10.1158/1078-0432.CCR-14-2565 |
0.01 |
|
| 2015 |
Henning J, Frangos S, Simon R, Pachter HL, Bholat OS. Patterns of traumatic injury in New York City prisoners requiring hospital admission. Journal of Correctional Health Care : the Official Journal of the National Commission On Correctional Health Care. 21: 53-8. PMID 25559630 DOI: 10.1177/1078345814558046 |
0.01 |
|
| 2015 |
Quaas A, Rahvar AH, Burdelski C, Koop C, Eichelberg C, Rink M, Dahlem R, Schlomm T, Tsourlakis MC, Simon R, Minner S, Sauter G, Steurer S. βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinoma. World Journal of Urology. 33: 1561-9. PMID 25527909 DOI: 10.1007/s00345-014-1463-6 |
0.01 |
|
| 2015 |
Camacho A, Núñez N, Dekomien G, Hernández-Laín A, de Aragón AM, Simón R. LAMA2-related congenital muscular dystrophy complicated by West syndrome. European Journal of Paediatric Neurology : Ejpn : Official Journal of the European Paediatric Neurology Society. 19: 243-7. PMID 25500573 DOI: 10.1016/j.ejpn.2014.11.005 |
0.01 |
|
| 2015 |
Gu L, Frommel SC, Oakes CC, Simon R, Grupp K, Gerig CY, Bär D, Robinson MD, Baer C, Weiss M, Gu Z, Schapira M, Kuner R, Sültmann H, Provenzano M, et al. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence. Nature Genetics. 47: 22-30. PMID 25485837 DOI: 10.1038/Ng.3165 |
0.01 |
|
| 2015 |
Simon RM, Salama JK, Freedland SJ. Radical prostatectomy versus radiation therapy: can pretreatment nomograms be used to select the appropriate prostate cancer treatment? European Urology. 67: 210-1. PMID 25457494 DOI: 10.1016/j.eururo.2014.10.009 |
0.01 |
|
| 2015 |
Simon RM, Freedland SJ, Vidal AC. Editorial Comment to Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery International Journal of Urology. 22: 88. PMID 25208854 DOI: 10.1111/iju.12621 |
0.01 |
|
| 2015 |
Johansson LB, Simon R, Bergström G, Eriksson M, Prokop S, Mandenius CF, Heppner FL, Åslund AK, Nilsson KP. An azide functionalized oligothiophene ligand--a versatile tool for multimodal detection of disease associated protein aggregates. Biosensors & Bioelectronics. 63: 204-11. PMID 25089818 DOI: 10.1016/J.Bios.2014.07.042 |
0.01 |
|
| 2015 |
Simon RM, Kim T, Espiritu P, Kurian T, Sexton WJ, Pow-Sang JM, Sverrisson E, Spiess PE. Effect of utilization of veno-venous bypass vs. cardiopulmonary bypass on complications for high level inferior vena cava tumor thrombectomy and concomitant radical nephrectomy International Braz J Urol. 41: 911-919. DOI: 10.1590/S1677-5538.IBJU.2014.0371 |
0.01 |
|
| 2015 |
Ding JZ, McIntosh KA, Simon RM. New device for measuring drilled shaft bottom sediment thickness Dfi Journal. 9: 42-47. DOI: 10.1179/1937525515Y.0000000004 |
0.01 |
|
| 2015 |
Cummins S, Peltier JW, Pomirleanu N, Cross J, Simon R. Evaluating Educational Practices for Positively Affecting Student Perceptions of a Sales Career Journal of Marketing Education. 37: 25-35. DOI: 10.1177/0273475314568431 |
0.01 |
|
| 2015 |
Andrea K, Simon R. Design and evaluation of an RPL-based multi-sink routing protocol for low-power and lossy networks Mswim 2015 - Proceedings of the 18th Acm International Conference On Modeling, Analysis and Simulation of Wireless and Mobile Systems. 141-150. DOI: 10.1145/2811587.2811614 |
0.01 |
|
| 2015 |
Abdi H, Labrie D, Nguyen TS, Barnichon JD, Su G, Evgin E, Simon R, Fall M. Laboratory investigation on the mechanical behaviour of Tournemire argillite Canadian Geotechnical Journal. 52: 268-282. DOI: 10.1139/cgj-2013-0122 |
0.01 |
|
| 2015 |
Bandari M, Simon R, Aydin H. Energy management of embedded wireless systems through voltage and modulation scaling under probabilistic workloads 2014 International Green Computing Conference, Igcc 2014. DOI: 10.1109/IGCC.2014.7039168 |
0.01 |
|
| 2015 |
Bandari M, Simon R, Aydin H. Power management in cluster-based energy-harvesting sensor networks through dynamic modulation scaling Proceedings - 2015 Ieee 17th International Conference On High Performance Computing and Communications, 2015 Ieee 7th International Symposium On Cyberspace Safety and Security and 2015 Ieee 12th International Conference On Embedded Software and Systems, Hpcc-Css-Icess 2015. 925-933. DOI: 10.1109/HPCC-CSS-ICESS.2015.153 |
0.01 |
|
| 2015 |
Roshi DA, Warnick KF, Brandt J, Fisher JR, Ford P, Jeffs BD, Marganian P, McLeod M, Mello M, Morgan M, Norrod R, Shillue W, Simon R, White S. A 19 element cryogenic phased array feed for the Green Bank Telescope Ieee Antennas and Propagation Society, Ap-S International Symposium (Digest). 2015: 1376-1377. DOI: 10.1109/APS.2015.7305077 |
0.01 |
|
| 2015 |
Simon RA, Quddus MR, Lawrence WD, Sung CJ. Pathology of endometrial ablation failures: A clinicopathologic study of 164 cases International Journal of Gynecological Pathology. 34: 245-252. DOI: 10.1097/PGP.0000000000000147 |
0.01 |
|
| 2015 |
Simon R, Dresselhaus T. Peptides take centre stage in plant signalling Journal of Experimental Botany. 66: 5135-5138. DOI: 10.1093/jxb/erv376 |
0.01 |
|
| 2015 |
Adams JD, Herter TL, Hora JL, Schneider N, Lau RM, Staguhn JG, Simon R, Smith N, Gehrz RD, Allen LE, Bontemps S, Carey SJ, Fazio GG, Gutermuth RA, Fernandez AG, et al. Sofia/forcast observations of warm dust in S106: A fragmented environment Astrophysical Journal. 814. DOI: 10.1088/0004-637X/814/1/54 |
0.01 |
|
| 2015 |
Frayer DT, Maddalena RJ, Meijer M, Hough L, White S, Norrod R, Watts G, Stennes M, Simon R, Woody D, Srikanth S, Pospieszalski M, Bryerton E, Whitehead M, Ford P, et al. The GBT 67-93.6 GHZ spectral line survey of ORION-KL Astronomical Journal. 149. DOI: 10.1088/0004-6256/149/5/162 |
0.01 |
|
| 2015 |
Sun H, Simon RB, Pomeroy JW, Francis D, Faili F, Twitchen DJ, Kuball M. Reducing GaN-on-diamond interfacial thermal resistance for high power transistor applications Applied Physics Letters. 106. DOI: 10.1063/1.4913430 |
0.01 |
|
| 2015 |
Pérez-Beaupuits JP, Güsten R, Spaans M, Ossenkopf V, Menten KM, Requena-Torres MA, Wiesemeyer H, Stutzki J, Guevara C, Simon R. Disentangling the excitation conditions of the dense gas in M17 SW Astronomy and Astrophysics. 583. DOI: 10.1051/0004-6361/201526441 |
0.01 |
|
| 2015 |
Ossenkopf V, Koumpia E, Okada Y, Mookerjea B, Van Der Tak FFS, Simon R, Pütz P, Güsten R. Fine-structure line deficit in S 140 Astronomy and Astrophysics. 580. DOI: 10.1051/0004-6361/201526231 |
0.01 |
|
| 2015 |
Schneider N, Csengeri T, Klessen RS, Tremblin P, Ossenkopf V, Peretto N, Simon R, Bontemps S, Federrath C. Understanding star formation in molecular clouds: II. Signatures of gravitational collapse of IRDCs Astronomy and Astrophysics. 578. DOI: 10.1051/0004-6361/201424375 |
0.01 |
|
| 2015 |
Richter N, Simon RC, Lechner H, Kroutil W, Ward JM, Hailes HC. ω-Transaminases for the amination of functionalised cyclic ketones Organic and Biomolecular Chemistry. 13: 8843-8851. DOI: 10.1039/c5ob01204j |
0.01 |
|
| 2015 |
Bandari M, Simon R, Aydin H. On minimizing expected energy usage of embedded wireless systems with probabilistic workloads Sustainable Computing: Informatics and Systems. DOI: 10.1016/J.Suscom.2016.02.004 |
0.01 |
|
| 2015 |
Simon RP. Epigenetic modulation of gene expression governs the brain's response to injury Neuroscience Letters. DOI: 10.1016/j.neulet.2015.12.024 |
0.01 |
|
| 2015 |
Ben Abdelghani F, Aubertin M, Simon R, Therrien R. Numerical simulations of water flow and contaminants transport near mining wastes disposed in a fractured rock mass International Journal of Mining Science and Technology. 25: 37-45. DOI: 10.1016/J.Ijmst.2014.11.003 |
0.01 |
|
| 2015 |
Wu H, Zhang J, Simon R. A method of introducing CAD to ePLC for motion control Ifac Proceedings Volumes (Ifac-Papersonline). 48: 1580-1585. DOI: 10.1016/j.ifacol.2015.06.311 |
0.01 |
|
| 2015 |
Simon RS. The challenge of non-zero-sum stochastic games International Journal of Game Theory. DOI: 10.1007/s00182-015-0497-3 |
0.01 |
|
| 2015 |
Schmidt NG, Simon RC, Kroutil W. Biocatalytic asymmetric synthesis of optically pure aromatic propargylic amines employing ω-transaminases Advanced Synthesis and Catalysis. 357: 1815-1821. DOI: 10.1002/adsc.201500086 |
0.01 |
|
| 2014 |
Burdelski C, Matuszewska A, Kluth M, Koop C, Grupp K, Steurer S, Wittmer C, Minner S, Tsourlakis MC, Sauter G, Schlomm T, Simon R. Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer. Microarrays (Basel, Switzerland). 3: 137-58. PMID 27600340 DOI: 10.3390/microarrays3020137 |
0.01 |
|
| 2014 |
Simon RW. Anesthetic management and implications of pediatric patients with a diagnosis of anti-N-methyl-D-aspartate receptor encephalitis: two case reports. Aana Journal. 82: 431-6. PMID 25842641 |
0.01 |
|
| 2014 |
Simon R. Biomarker based clinical trial design. Chinese Clinical Oncology. 3: 39. PMID 25841465 DOI: 10.3978/j.issn.2304-3865.2014.02.03 |
0.01 |
|
| 2014 |
Simon R. Post-conditioning and reperfusion injury in the treatment of stroke. Dose-Response : a Publication of International Hormesis Society. 12: 590-9. PMID 25552959 DOI: 10.2203/dose-response.14-026.Simon |
0.01 |
|
| 2014 |
Mogayzel PJ, Naureckas ET, Robinson KA, Brady C, Guill M, Lahiri T, Lubsch L, Matsui J, Oermann CM, Ratjen F, Rosenfeld M, Simon RH, Hazle L, Sabadosa K, Marshall BC, et al. Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Annals of the American Thoracic Society. 11: 1640-50. PMID 25549030 DOI: 10.1513/Annalsats.201404-166Oc |
0.01 |
|
| 2014 |
Uzunoglu FG, Dethlefsen E, Hanssen A, Wrage M, Deutsch L, Harms-Effenberger K, Vashist YK, Reeh M, Sauter G, Simon R, Bockhorn M, Pantel K, Izbicki JR, Wikman H. Loss of 4q21.23-22.1 is a prognostic marker for disease free and overall survival in non-small cell lung cancer. Plos One. 9: e113315. PMID 25501003 DOI: 10.1371/journal.pone.0113315 |
0.01 |
|
| 2014 |
Magnusson K, Simon R, Sjölander D, Sigurdson CJ, Hammarström P, Nilsson KP. Multimodal fluorescence microscopy of prion strain specific PrP deposits stained by thiophene-based amyloid ligands. Prion. 8: 319-29. PMID 25495506 DOI: 10.4161/Pri.29239 |
0.01 |
|
| 2014 |
Simon R. Substitutive hormonal therapy in menopause women. Panminerva Medica. 56: 285-7. PMID 25424462 |
0.01 |
|
| 2014 |
Fereres S, Simón R, Mohd-Sarip A, Verrijzer CP, Busturia A. dRYBP counteracts chromatin-dependent activation and repression of transcription. Plos One. 9: e113255. PMID 25415640 DOI: 10.1371/journal.pone.0113255 |
0.01 |
|
| 2014 |
Burandt E, Bari Noubar T, Lebeau A, Minner S, Burdelski C, Jänicke F, Müller V, Terracciano L, Simon R, Sauter G, Wilczak W, Lebok P. Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer: a TMA-based immunohistochemical study on 2,197 breast cancer patients. Oncology Reports. 32: 2628-34. PMID 25270339 DOI: 10.3892/or.2014.3523 |
0.01 |
|
| 2014 |
Sampson HA, Aceves S, Bock SA, James J, Jones S, Lang D, Nadeau K, Nowak-Wegrzyn A, Oppenheimer J, Perry TT, Randolph C, Sicherer SH, Simon RA, Vickery BP, Wood R, ... ... Simon RA, et al. Food allergy: a practice parameter update-2014. The Journal of Allergy and Clinical Immunology. 134: 1016-25.e43. PMID 25174862 DOI: 10.1016/J.Jaci.2014.05.013 |
0.01 |
|
| 2014 |
Steurer S, Singer JM, Rink M, Chun F, Dahlem R, Simon R, Burandt E, Stahl P, Terracciano L, Schlomm T, Wagner W, Höppner W, Omidi M, Kraus O, Kwiatkowski M, et al. MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays. Urologic Oncology. 32: 1225-33. PMID 25131659 DOI: 10.1016/j.urolonc.2014.06.007 |
0.01 |
|
| 2014 |
Brocks D, Assenov Y, Minner S, Bogatyrova O, Simon R, Koop C, Oakes C, Zucknick M, Lipka DB, Weischenfeldt J, Feuerbach L, Cowper-Sal Lari R, Lupien M, Brors B, Korbel J, et al. Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer. Cell Reports. 8: 798-806. PMID 25066126 DOI: 10.1016/J.Celrep.2014.06.053 |
0.01 |
|
| 2014 |
Steurer S, Mayer PS, Adam M, Krohn A, Koop C, Ospina-Klinck D, Tehrani AA, Simon R, Tennstedt P, Graefen M, Wittmer C, Brors B, Plass C, Korbel J, Weischenfeldt J, et al. TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer. European Urology. 66: 978-81. PMID 25015038 DOI: 10.1016/J.Eururo.2014.06.027 |
0.01 |
|
| 2014 |
Simon R, Mirlacher M, Sauter G. Tissue microarrays for early target evaluation. Drug Discovery Today. Technologies. 1: 41-8. PMID 24981266 DOI: 10.1016/j.ddtec.2004.08.003 |
0.01 |
|
| 2014 |
Burandt E, Grünert M, Lebeau A, Choschzick M, Quaas A, Jänicke F, Müller V, Scholz U, Bokemeyer C, Petersen C, Geist S, Paluchowski P, Wilke C, Heilenkötter U, Simon R, et al. Cyclin D1 gene amplification is highly homogeneous in breast cancer. Breast Cancer (Tokyo, Japan). PMID 24862872 DOI: 10.1007/s12282-014-0538-y |
0.01 |
|
| 2014 |
Kluth M, Reynolds K, Rink M, Chun F, Dahlem R, Fisch M, Höppner W, Wagner W, Doh O, Terracciano L, Simon R, Sauter G, Minner S. Reduced membranous MET expression is linked to bladder cancer progression. Cancer Genetics. 207: 147-52. PMID 24853099 DOI: 10.1016/j.cancergen.2014.03.008 |
0.01 |
|
| 2014 |
Glass NE, Frangos SG, Simon RJ, Bholat OS, Todd SR, Wilson C, Jacko S, Slaughter D, Foltin G, Levine DA. Risky behaviors associated with pediatric pedestrians and bicyclists struck by motor vehicles. Pediatric Emergency Care. 30: 409-12. PMID 24849277 DOI: 10.1097/PEC.0000000000000148 |
0.01 |
|
| 2014 |
Grupp K, Ospina-Klinck D, Tsourlakis MC, Koop C, Wilczak W, Adam M, Simon R, Sauter G, Izbicki JR, Graefen M, Huland H, Steurer S, Schlomm T, Minner S, Quaas A. NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer. The Prostate. 74: 1012-22. PMID 24789172 DOI: 10.1002/pros.22816 |
0.01 |
|
| 2014 |
Steurer S, Seddiqi AS, Singer JM, Bahar AS, Eichelberg C, Rink M, Dahlem R, Huland H, Sauter G, Simon R, Minner S, Burandt E, Stahl PR, Schlomm T, Wurlitzer M, et al. MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype. Anticancer Research. 34: 2255-61. PMID 24778028 |
0.01 |
|
| 2014 |
Krohn A, Freudenthaler F, Harasimowicz S, Kluth M, Fuchs S, Burkhardt L, Stahl P, C Tsourlakis M, Bauer M, Tennstedt P, Graefen M, Steurer S, Sirma H, Sauter G, Schlomm T, ... Simon R, et al. Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 27: 1612-20. PMID 24762546 DOI: 10.1038/modpathol.2014.70 |
0.01 |
|
| 2014 |
Scott DR, Simon RA. Supraesophageal reflux disease: a review of the literature. Allergy and Asthma Proceedings : the Official Journal of Regional and State Allergy Societies. 35: 104-10. PMID 24717786 DOI: 10.2500/aap.2014.35.3719 |
0.01 |
|
| 2014 |
Mader M, Simon R, Kurtz S. FISH Oracle 2: a web server for integrative visualization of genomic data in cancer research. Journal of Clinical Bioinformatics. 4: 5. PMID 24684958 DOI: 10.1186/2043-9113-4-5 |
0.01 |
|
| 2014 |
Slaughter DR, Williams N, Wall SP, Glass NE, Simon R, Todd SR, Bholat OS, Jacko S, Roe M, Wilson CT, Levine DA, Marshall G, Ayoung-Chee P, Pachter HL, Frangos SG. A community traffic safety analysis of pedestrian and bicyclist injuries based on the catchment area of a trauma center. The Journal of Trauma and Acute Care Surgery. 76: 1103-10. PMID 24662878 DOI: 10.1097/TA.0000000000000176 |
0.01 |
|
| 2014 |
Hanken H, Gaudin R, Gröbe A, Fraederich M, Eichhorn W, Smeets R, Simon R, Sauter G, Grupp K, Izbicki JR, Sehner S, Heiland M, Blessmann M. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 43: 304-8. PMID 24645976 DOI: 10.1111/jop.12173 |
0.01 |
|
| 2014 |
Rajan JP, Simon RA, Bosso JV. Prevalence of sensitivity to food and drug additives in patients with chronic idiopathic urticaria. The Journal of Allergy and Clinical Immunology. in Practice. 2: 168-71. PMID 24607044 DOI: 10.1016/j.jaip.2013.10.002 |
0.01 |
|
| 2014 |
Rawnaq T, Dietrich L, Wolters-Eisfeld G, Uzunoglu FG, Vashist YK, Bachmann K, Simon R, Izbicki JR, Bockhorn M, Güngör C. The multifunctional growth factor midkine promotes proliferation and migration in pancreatic cancer. Molecular Cancer Research : McR. 12: 670-80. PMID 24567526 DOI: 10.1158/1541-7786.MCR-13-0467 |
0.01 |
|
| 2014 |
Lange T, Kupfernagel M, Wicklein D, Gebauer F, Maar H, Brügge K, Müller I, Simon R, Schlomm T, Sauter G, Schumacher U. Aberrant presentation of HPA-reactive carbohydrates implies Selectin-independent metastasis formation in human prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 1791-802. PMID 24526735 DOI: 10.1158/1078-0432.CCR-13-2308 |
0.01 |
|
| 2014 |
Kluth M, Harasimowicz S, Burkhardt L, Grupp K, Krohn A, Prien K, Gjoni J, Haß T, Galal R, Graefen M, Haese A, Simon R, Hühne-Simon J, Koop C, Korbel J, et al. Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer. International Journal of Cancer. Journal International Du Cancer. 135: 1369-80. PMID 24523142 DOI: 10.1002/Ijc.28784 |
0.01 |
|
| 2014 |
Grupp K, Boumesli R, Tsourlakis MC, Koop C, Wilczak W, Adam M, Sauter G, Simon R, Izbicki JR, Graefen M, Huland H, Steurer S, Schlomm T, Minner S, Quaas A. The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression. International Journal of Cancer. Journal International Du Cancer. 135: 1399-407. PMID 24510842 DOI: 10.1002/ijc.28778 |
0.01 |
|
| 2014 |
Tennstedt P, Strobel G, Bölch C, Grob T, Minner S, Masser S, Simon R. Patterns of ALK expression in different human cancer types. Journal of Clinical Pathology. 67: 477-81. PMID 24478382 DOI: 10.1136/jclinpath-2013-201991 |
0.01 |
|
| 2014 |
Grupp K, Wilking J, Prien K, Hube-Magg C, Sirma H, Simon R, Steurer S, Budäus L, Haese A, Izbicki J, Sauter G, Minner S, Schlomm T, Tsourlakis MC. High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions. European Journal of Cancer (Oxford, England : 1990). 50: 852-61. PMID 24380696 DOI: 10.1016/j.ejca.2013.12.003 |
0.01 |
|
| 2014 |
Tsourlakis MC, Weigand P, Grupp K, Kluth M, Steurer S, Schlomm T, Graefen M, Huland H, Salomon G, Steuber T, Wilczak W, Sirma H, Simon R, Sauter G, Minner S, et al. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion. The American Journal of Pathology. 184: 609-17. PMID 24378408 DOI: 10.1016/j.ajpath.2013.11.007 |
0.01 |
|
| 2014 |
Tennstedt P, Bölch C, Strobel G, Minner S, Burkhardt L, Grob T, Masser S, Sauter G, Schlomm T, Simon R. Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR. International Journal of Oncology. 44: 609-15. PMID 24317684 DOI: 10.3892/ijo.2013.2200 |
0.01 |
|
| 2014 |
Militello KT, Mandarano AH, Varechtchouk O, Simon RD. Cytosine DNA methylation influences drug resistance in Escherichia coli through increased sugE expression. Fems Microbiology Letters. 350: 100-6. PMID 24164619 DOI: 10.1111/1574-6968.12299 |
0.01 |
|
| 2014 |
Gröbe A, Eichhorn W, Fraederich M, Kluwe L, Vashist Y, Wikner J, Smeets R, Simon R, Sauter G, Heiland M, Blessmann M. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 43: 205-10. PMID 24020871 DOI: 10.1111/jop.12111 |
0.01 |
|
| 2014 |
Grupp K, Habermann M, Sirma H, Simon R, Steurer S, Hube-Magg C, Prien K, Burkhardt L, Jedrzejewska K, Salomon G, Heinzer H, Wilczak W, Kluth M, Izbicki JR, Sauter G, et al. High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 27: 96-106. PMID 23887301 DOI: 10.1038/modpathol.2013.127 |
0.01 |
|
| 2014 |
Hanken H, Gröbe A, Cachovan G, Smeets R, Simon R, Sauter G, Heiland M, Blessmann M. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas. Clinical Oral Investigations. 18: 269-76. PMID 23494454 DOI: 10.1007/s00784-013-0967-6 |
0.01 |
|
| 2014 |
Gröbe A, Hanken H, Al-Dam A, Cachovan G, Smeets R, Krohn A, Clauditz T, Grob T, Simon R, Sauter G, Kluwe L, Heiland M, Blessmann M. P53 immunohistochemical expression does not correlate with clinical features in 207 carcinomas of the oral cavity and in the head and neck region. Clinical Oral Investigations. 18: 211-7. PMID 23404560 DOI: 10.1007/s00784-013-0939-x |
0.01 |
|
| 2013 |
Moelans CB, Holst F, Hellwinkel O, Simon R, van Diest PJ. ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous. Plos One. 8: e84189. PMID 24367641 DOI: 10.1371/journal.pone.0084189 |
0.01 |
|
| 2013 |
Grupp K, Jedrzejewska K, Tsourlakis MC, Koop C, Wilczak W, Adam M, Quaas A, Sauter G, Simon R, Izbicki JR, Graefen M, Huland H, Schlomm T, Minner S, Steurer S. High mitochondria content is associated with prostate cancer disease progression. Molecular Cancer. 12: 145. PMID 24261794 DOI: 10.1186/1476-4598-12-145 |
0.01 |
|
| 2013 |
König AM, Reeh M, Dancau AM, Rathjens M, Gros S, Uzunoglu FG, Bockhorn M, Simon R, Sauter G, Marx A, Izbicki JR. Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma. Anticancer Research. 33: 4975-82. PMID 24222138 |
0.01 |
|
| 2013 |
Sirma H, Broemel M, Stumm L, Tsourlakis T, Steurer S, Tennstedt P, Salomon G, Michl U, Haese A, Simon R, Sauter G, Schlomm T, Minner S. Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis. Oncology Letters. 6: 1245-1252. PMID 24179503 DOI: 10.3892/ol.2013.1563 |
0.01 |
|
| 2013 |
Webman R, Dultz LA, Simon RJ, Todd SR, Slaughter D, Jacko S, Bholat O, Wall S, Wilson C, Levine DA, Roe M, Pachter HL, Frangos SG. Helmet use is associated with safer bicycling behaviors and reduced hospital resource use following injury. The Journal of Trauma and Acute Care Surgery. 75: 877-81. PMID 24158210 DOI: 10.1097/TA.0b013e3182a85f97 |
0.01 |
|
| 2013 |
Sim V, Bernstein MP, Frangos SG, Wilson CT, Simon RJ, McStay CM, Huang PP, Pachter HL, Todd SR. The (f)utility of flexion-extension C-spine films in the setting of trauma. American Journal of Surgery. 206: 929-33; discussion 9. PMID 24139671 DOI: 10.1016/j.amjsurg.2013.09.001 |
0.01 |
|
| 2013 |
Qu Y, Oyan AM, Liu R, Hua Y, Zhang J, Hovland R, Popa M, Liu X, Brokstad KA, Simon R, Molven A, Lin B, Zhang WD, McCormack E, Kalland KH, et al. Generation of prostate tumor-initiating cells is associated with elevation of reactive oxygen species and IL-6/STAT3 signaling. Cancer Research. 73: 7090-100. PMID 24101153 DOI: 10.1158/0008-5472.CAN-13-1560 |
0.01 |
|
| 2013 |
Cordes I, Kluth M, Zygis D, Rink M, Chun F, Eichelberg C, Dahlem R, Fisch M, Höppner W, Wagner W, Doh O, Terracciano L, Simon R, Wilczak W, Sauter G, et al. PTEN deletions are related to disease progression and unfavourable prognosis in early bladder cancer. Histopathology. 63: 670-7. PMID 24004025 DOI: 10.1111/his.12209 |
0.01 |
|
| 2013 |
Grupp K, Höhne TS, Prien K, Hube-Magg C, Tsourlakis MC, Sirma H, Pham T, Heinzer H, Graefen M, Michl U, Simon R, Wilczak W, Izbicki J, Sauter G, Minner S, et al. Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy. Experimental and Molecular Pathology. 95: 227-34. PMID 23948277 DOI: 10.1016/j.yexmp.2013.08.002 |
0.01 |
|
| 2013 |
Grupp K, Sanader S, Sirma H, Simon R, Koop C, Prien K, Hube-Magg C, Salomon G, Graefen M, Heinzer H, Minner S, Izbicki JR, Sauter G, Schlomm T, Tsourlakis MC. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers. Molecular Oncology. 7: 1001-11. PMID 23941784 DOI: 10.1016/j.molonc.2013.07.009 |
0.01 |
|
| 2013 |
Quaas A, Bahar AS, von Loga K, Seddiqi AS, Singer JM, Omidi M, Kraus O, Kwiatkowski M, Trusch M, Minner S, Burandt E, Stahl P, Wilczak W, Wurlitzer M, Simon R, et al. MALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer. Histopathology. 63: 455-62. PMID 23855813 DOI: 10.1111/his.12193 |
0.01 |
|
| 2013 |
Grupp K, Diebel F, Sirma H, Simon R, Breitmeyer K, Steurer S, Hube-Magg C, Prien K, Pham T, Weigand P, Michl U, Heinzer H, Kluth M, Minner S, Tsourlakis MC, et al. SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence. The Prostate. 73: 1690-8. PMID 23843146 DOI: 10.1002/pros.22707 |
0.01 |
|
| 2013 |
Krohn A, Seidel A, Burkhardt L, Bachmann F, Mader M, Grupp K, Eichenauer T, Becker A, Adam M, Graefen M, Huland H, Kurtz S, Steurer S, Tsourlakis MC, Minner S, ... ... Simon R, et al. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers. The Journal of Pathology. 231: 130-41. PMID 23794398 DOI: 10.1002/path.4223 |
0.01 |
|
| 2013 |
Gröbe A, Hanken H, Kluwe L, Schöllchen M, Tribius S, Pohlenz P, Clauditz T, Grob T, Simon R, Sauter G, Heiland M, Blessmann M. Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 42: 676-81. PMID 23721566 DOI: 10.1111/jop.12086 |
0.01 |
|
| 2013 |
Tsourlakis MC, Schoop M, Plass C, Huland H, Graefen M, Steuber T, Schlomm T, Simon R, Sauter G, Sirma H, Minner S. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence. Human Pathology. 44: 1789-96. PMID 23642739 DOI: 10.1016/J.Humpath.2013.01.022 |
0.01 |
|
| 2013 |
Woessner KM, Simon RA. Cardiovascular prophylaxis and aspirin "allergy". Immunology and Allergy Clinics of North America. 33: 263-74. PMID 23639713 DOI: 10.1016/j.iac.2012.11.004 |
0.01 |
|
| 2013 |
Stumm L, Burkhardt L, Steurer S, Simon R, Adam M, Becker A, Sauter G, Minner S, Schlomm T, Sirma H, Michl U. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers. Journal of Clinical Pathology. 66: 563-8. PMID 23559350 DOI: 10.1136/jclinpath-2012-201335 |
0.01 |
|
| 2013 |
Wik E, Birkeland E, Trovik J, Werner HM, Hoivik EA, Mjos S, Krakstad C, Kusonmano K, Mauland K, Stefansson IM, Holst F, Petersen K, Oyan AM, Simon R, Kalland KH, et al. High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2331-41. PMID 23538402 DOI: 10.1158/1078-0432.CCR-12-3413 |
0.01 |
|
| 2013 |
Dultz LA, Foltin G, Simon R, Wall SP, Levine DA, Bholat O, Slaughter-Larkem D, Jacko S, Marr M, Glass NE, Pachter HL, Frangos SG. Vulnerable roadway users struck by motor vehicles at the center of the safest, large US city. The Journal of Trauma and Acute Care Surgery. 74: 1138-45. PMID 23511157 DOI: 10.1097/TA.0b013e31827ab722 |
0.01 |
|
| 2013 |
Burkhardt L, Fuchs S, Krohn A, Masser S, Mader M, Kluth M, Bachmann F, Huland H, Steuber T, Graefen M, Schlomm T, Minner S, Sauter G, Sirma H, Simon R. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. Cancer Research. 73: 2795-805. PMID 23492366 DOI: 10.1158/0008-5472.CAN-12-1342 |
0.01 |
|
| 2013 |
White AA, Stevenson DD, Woessner KM, Simon RA. Approach to patients with aspirin hypersensitivity and acute cardiovascular emergencies. Allergy and Asthma Proceedings : the Official Journal of Regional and State Allergy Societies. 34: 138-42. PMID 23484888 DOI: 10.2500/aap.2013.34.3644 |
0.01 |
|
| 2013 |
Blessmann M, Al-Dam A, Hanken H, Assaf AT, Riecke B, Klatt J, Simon R, Sauter G, Heiland M, Kluwe L, Gröbe A. Amplification of the PPFIA1 gene region on 11q13 in oral squamous cell carcinomas (OSCC). Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association For Cranio-Maxillo-Facial Surgery. 41: 845-9. PMID 23453270 DOI: 10.1016/j.jcms.2013.01.040 |
0.01 |
|
| 2013 |
Choschzick M, Hess S, Grob T, Burandt E, Wölber L, Simon R, Sauter G. HER2 amplification in squamous cell carcinomas of the vulva. Histopathology. 62: 965-7. PMID 23444903 DOI: 10.1111/his.12090 |
0.01 |
|
| 2013 |
Weischenfeldt J, Simon R, Feuerbach L, Schlangen K, Weichenhan D, Minner S, Wuttig D, Warnatz HJ, Stehr H, Rausch T, Jäger N, Gu L, Bogatyrova O, Stütz AM, Claus R, et al. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell. 23: 159-70. PMID 23410972 DOI: 10.1016/J.Ccr.2013.01.002 |
0.01 |
|
| 2013 |
Raeder MB, Birkeland E, Trovik J, Krakstad C, Shehata S, Schumacher S, Zack TI, Krohn A, Werner HM, Moody SE, Wik E, Stefansson IM, Holst F, Oyan AM, Tamayo P, ... ... Simon R, et al. Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. Plos One. 8: e54873. PMID 23393560 DOI: 10.1371/Journal.Pone.0054873 |
0.01 |
|
| 2013 |
Steurer S, Borkowski C, Odinga S, Buchholz M, Koop C, Huland H, Becker M, Witt M, Trede D, Omidi M, Kraus O, Bahar AS, Seddiqi AS, Singer JM, Kwiatkowski M, ... ... Simon R, et al. MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays. International Journal of Cancer. Journal International Du Cancer. 133: 920-8. PMID 23381989 DOI: 10.1002/ijc.28080 |
0.01 |
|
| 2013 |
Kluth M, Hesse J, Heinl A, Krohn A, Steurer S, Sirma H, Simon R, Mayer PS, Schumacher U, Grupp K, Izbicki JR, Pantel K, Dikomey E, Korbel JO, Plass C, et al. Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 975-83. PMID 23370768 DOI: 10.1038/Modpathol.2012.236 |
0.01 |
|
| 2013 |
Flammiger A, Weisbach L, Huland H, Tennstedt P, Simon R, Minner S, Bokemeyer C, Sauter G, Schlomm T, Trepel M. High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer. European Journal of Cancer (Oxford, England : 1990). 49: 1273-9. PMID 23266046 DOI: 10.1016/j.ejca.2012.11.035 |
0.01 |
|
| 2013 |
Grob TJ, Hoenig T, Clauditz TS, Atanackovic D, Koenig AM, Vashist YK, Klose H, Simon R, Pantel K, Izbicki JR, Bokemeyer C, Sauter G, Wilczak W. Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 79: 221-7. PMID 23238037 DOI: 10.1016/j.lungcan.2012.11.009 |
0.01 |
|
| 2013 |
Grupp K, Kohl S, Sirma H, Simon R, Steurer S, Becker A, Adam M, Izbicki J, Sauter G, Minner S, Schlomm T, Tsourlakis MC. Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 733-42. PMID 23196798 DOI: 10.1038/modpathol.2012.206 |
0.01 |
|
| 2013 |
Tennstedt P, Fresow R, Simon R, Marx A, Terracciano L, Petersen C, Sauter G, Dikomey E, Borgmann K. RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma. International Journal of Cancer. 132: 2118-26. PMID 23065657 DOI: 10.1002/ijc.27907 |
0.01 |
|
| 2013 |
Müller J, Ehlers A, Burkhardt L, Sirma H, Steuber T, Graefen M, Sauter G, Minner S, Simon R, Schlomm T, Michl U. Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers International Journal of Cancer. 132: 1333-1340. PMID 22886792 DOI: 10.1002/ijc.27768 |
0.01 |
|
| 2012 |
Minner S, Krohn A, Sirma H, Simon R, Graefen M, Sauter G, Schlomm T. Association of nuclear accumulation of p53 with ERG fusion and poor prognosis in prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 124. PMID 28143250 DOI: 10.1200/jco.2012.30.5_suppl.124 |
0.01 |
|
| 2012 |
Minner S, Krohn A, Sirma H, Simon R, Graefen M, Sauter G, Schlomm T. Association of nuclear accumulation of p53 with ERG fusion and poor prognosis in prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 124. PMID 27968189 DOI: 10.1200/jco.2012.30.5_suppl.124 |
0.01 |
|
| 2012 |
Jacobsen F, Ashtiani SN, Tennstedt P, Heinzer H, Simon R, Sauter G, Sirma H, Tsourlakis MC, Minner S, Schlomm T, Michl U. High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer. Experimental and Therapeutic Medicine. 5: 102-106. PMID 23251249 DOI: 10.3892/etm.2012.764 |
0.01 |
|
| 2012 |
Gromova I, Gromov P, Kroman N, Wielenga VT, Simon R, Sauter G, Moreira JM. Immunoexpression analysis and prognostic value of BLCAP in breast cancer. Plos One. 7: e45967. PMID 23049907 DOI: 10.1371/journal.pone.0045967 |
0.01 |
|
| 2012 |
Flammiger A, Bayer F, Cirugeda-Kühnert A, Huland H, Tennstedt P, Simon R, Minner S, Bokemeyer C, Sauter G, Schlomm T, Trepel M. Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 120: 901-8. PMID 23009114 DOI: 10.1111/j.1600-0463.2012.02924.x |
0.01 |
|
| 2012 |
Börno ST, Fischer A, Kerick M, Fälth M, Laible M, Brase JC, Kuner R, Dahl A, Grimm C, Sayanjali B, Isau M, Röhr C, Wunderlich A, Timmermann B, Claus R, ... ... Simon R, et al. Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation. Cancer Discovery. 2: 1024-35. PMID 22930729 DOI: 10.1158/2159-8290.Cd-12-0041 |
0.01 |
|
| 2012 |
Minner S, Gärtner M, Freudenthaler F, Bauer M, Kluth M, Salomon G, Heinzer H, Graefen M, Bokemeyer C, Simon R, Sauter G, Schlomm T, Wilczak W. Marked heterogeneity of ERG expression in large primary prostate cancers. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 106-16. PMID 22899295 DOI: 10.1038/modpathol.2012.130 |
0.01 |
|
| 2012 |
Grob TJ, Kannengiesser I, Tsourlakis MC, Atanackovic D, Koenig AM, Vashist YK, Klose H, Marx AH, Koops S, Simon R, Izbicki JR, Bokemeyer C, Sauter G, Wilczak W. Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lung. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 25: 1566-73. PMID 22899293 DOI: 10.1038/modpathol.2012.125 |
0.01 |
|
| 2012 |
Minner S, De Silva C, Rink M, Dahlem R, Chun F, Fisch M, Höppner W, Wagner W, Bokemeyer C, Terracciano L, Simon R, Sauter G, Wilczak W. Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer. Pathology. 44: 448-52. PMID 22772340 DOI: 10.1097/PAT.0b013e32835576ee |
0.01 |
|
| 2012 |
Krohn A, Diedler T, Burkhardt L, Mayer PS, De Silva C, Meyer-Kornblum M, Kötschau D, Tennstedt P, Huang J, Gerhäuser C, Mader M, Kurtz S, Sirma H, Saad F, Steuber T, ... ... Simon R, et al. Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer. The American Journal of Pathology. 181: 401-12. PMID 22705054 DOI: 10.1016/J.Ajpath.2012.04.026 |
0.01 |
|
| 2012 |
Feng CH, Miller MD, Simon RA. The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis. American Journal of Rhinology & Allergy. 26: 187-90. PMID 22643942 DOI: 10.2500/ajra.2012.26.3762 |
0.01 |
|
| 2012 |
Mina S, Bohn BA, Simon R, Krohn A, Reeh M, Arnold D, Bokemeyer C, Sauter G, Izbicki JR, Marx A, Stahl PR. PTEN deletion is rare but often homogeneous in gastric cancer. Journal of Clinical Pathology. 65: 693-8. PMID 22639407 DOI: 10.1136/jclinpath-2011-200525 |
0.01 |
|
| 2012 |
Stevenson DD, White AA, Simon RA. Aspirin as a cause of pancreatitis in patients with aspirin-exacerbated respiratory disease. The Journal of Allergy and Clinical Immunology. 129: 1687-8. PMID 22554703 DOI: 10.1016/j.jaci.2012.04.016 |
0.01 |
|
| 2012 |
Chang JE, White A, Simon RA, Stevenson DD. Aspirin-exacerbated respiratory disease: burden of disease. Allergy and Asthma Proceedings : the Official Journal of Regional and State Allergy Societies. 33: 117-21. PMID 22525387 DOI: 10.2500/aap.2012.33.3541 |
0.01 |
|
| 2012 |
Choschzick M, Hess S, Tennstedt P, Holst F, Bohlken H, Gieseking F, Mahner S, Woelber L, Simon R, Sauter G. Role of cyclin D1 amplification and expression in vulvar carcinomas. Human Pathology. 43: 1386-93. PMID 22406359 DOI: 10.1016/j.humpath.2011.11.014 |
0.01 |
|
| 2012 |
Chang JE, Chin W, Simon R. Aspirin-sensitive asthma and upper airway diseases. American Journal of Rhinology & Allergy. 26: 27-30. PMID 22391075 DOI: 10.2500/ajra.2012.26.3721 |
0.01 |
|
| 2012 |
Duhamel S, Hébert J, Gaboury L, Bouchard A, Simon R, Sauter G, Basik M, Meloche S. Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation. Cancer Research. 72: 626-35. PMID 22298595 DOI: 10.1158/0008-5472.Can-11-2126 |
0.01 |
|
| 2012 |
Holst F, Moelans CB, Filipits M, Singer CF, Simon R, van Diest PJ. On the evidence for ESR1 amplification in breast cancer. Nature Reviews. Cancer. 12: 149. PMID 22270954 DOI: 10.1038/nrc3093-c3 |
0.01 |
|
| 2012 |
Hartmann S, Szaumkessel M, Salaverria I, Simon R, Sauter G, Kiwerska K, Gawecki W, Bodnar M, Marszalek A, Richter J, Brauze D, Zemke N, Jarmuz M, Hansmann ML, Siebert R, et al. Loss of protein expression and recurrent DNA hypermethylation of the GNG7 gene in squamous cell carcinoma of the head and neck. Journal of Applied Genetics. 53: 167-74. PMID 22183866 DOI: 10.1007/s13353-011-0079-4 |
0.01 |
|
| 2012 |
Minner S, Rump D, Tennstedt P, Simon R, Burandt E, Terracciano L, Moch H, Wilczak W, Bokemeyer C, Fisch M, Sauter G, Eichelberg C. Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma. Cancer. 118: 1268-75. PMID 22161775 DOI: 10.1002/cncr.26436 |
0.01 |
|
| 2012 |
Militello KT, Simon RD, Qureshi M, Maines R, VanHorne ML, Hennick SM, Jayakar SK, Pounder S. Conservation of Dcm-mediated cytosine DNA methylation in Escherichia coli. Fems Microbiology Letters. 328: 78-85. PMID 22150247 DOI: 10.1111/J.1574-6968.2011.02482.X |
0.01 |
|
| 2012 |
Abraham NE, Simon R, Shah O. Thermal injury causing delayed perforation of small bowel after transurethral resection of bladder tumor without evidence of bladder perforation. The Canadian Journal of Urology. 18: 5836-8. PMID 21854717 |
0.01 |
|
| 2011 |
Brase JC, Johannes M, Mannsperger H, Fälth M, Metzger J, Kacprzyk LA, Andrasiuk T, Gade S, Meister M, Sirma H, Sauter G, Simon R, Schlomm T, Beissbarth T, Korf U, et al. TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling. Bmc Cancer. 11: 507. PMID 22142399 DOI: 10.1186/1471-2407-11-507 |
0.01 |
|
| 2011 |
Dultz LA, Frangos S, Foltin G, Marr M, Simon R, Bholat O, Levine DA, Slaughter-Larkem D, Jacko S, Ayoung-Chee P, Pachter HL. Alcohol use by pedestrians who are struck by motor vehicles: how drinking influences behaviors, medical management, and outcomes. The Journal of Trauma. 71: 1252-7. PMID 22071927 DOI: 10.1097/TA.0b013e3182327c94 |
0.01 |
|
| 2011 |
Stieler K, Schindler S, Schlomm T, Hohn O, Bannert N, Simon R, Minner S, Schindler M, Fischer N. No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe. Plos One. 6: e25592. PMID 22022417 DOI: 10.1371/journal.pone.0025592 |
0.01 |
|
| 2011 |
Pearson HB, Perez-Mancera PA, Dow LE, Ryan A, Tennstedt P, Bogani D, Elsum I, Greenfield A, Tuveson DA, Simon R, Humbert PO. SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia. The Journal of Clinical Investigation. 121: 4257-67. PMID 21965329 DOI: 10.1172/Jci58509 |
0.01 |
|
| 2011 |
Stahl PR, Kilgué A, Tennstedt P, Minner S, Krohn A, Simon R, Krause GV, Izbicki J, Graefen M, Sauter G, Schlomm T, Wilczak W. Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age. The Prostate. 72: 898-903. PMID 21956681 DOI: 10.1002/pros.21492 |
0.01 |
|
| 2011 |
Tennstedt P, Köster P, Brüchmann A, Mirlacher M, Haese A, Steuber T, Sauter G, Huland H, Graefen M, Schlomm T, Minner S, Simon R. The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers. International Journal of Oncology. 40: 261-8. PMID 21956230 DOI: 10.3892/ijo.2011.1216 |
0.01 |
|
| 2011 |
Choschzick M, Heilenkötter U, Lebeau A, Jaenicke F, Terracciano L, Bokemeyer C, Sauter G, Simon R. MDM2 amplification is an independent prognostic feature of node-negative, estrogen receptor-positive early-stage breast cancer. Cancer Biomarkers : Section a of Disease Markers. 8: 53-60. PMID 21896991 DOI: 10.3233/DMA-2011-0806 |
0.01 |
|
| 2011 |
Mader M, Simon R, Steinbiss S, Kurtz S. FISH Oracle: a web server for flexible visualization of DNA copy number data in a genomic context. Journal of Clinical Bioinformatics. 1: 20. PMID 21884636 DOI: 10.1186/2043-9113-1-20 |
0.01 |
|
| 2011 |
Marx WH, Simon R, O'Neill P, Shapiro MJ, Cooper AC, Farrell LS, McCormack JE, Bessey PQ, Hannan E. The relationship between annual hospital volume of trauma patients and in-hospital mortality in New York State. The Journal of Trauma. 71: 339-45; discussion 3. PMID 21825936 DOI: 10.1097/TA.0b013e3182214055 |
0.01 |
|
| 2011 |
Choschzick M, Hantaredja W, Tennstedt P, Gieseking F, Wölber L, Simon R. Role of TP53 mutations in vulvar carcinomas. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 30: 497-504. PMID 21804386 DOI: 10.1097/PGP.0b013e3182184c7a |
0.01 |
|
| 2011 |
Minner S, Enodien M, Sirma H, Luebke AM, Krohn A, Mayer PS, Simon R, Tennstedt P, Müller J, Scholz L, Brase JC, Liu AY, Schlüter H, Pantel K, Schumacher U, et al. ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5878-88. PMID 21791629 DOI: 10.1158/1078-0432.CCR-11-1251 |
0.01 |
|
| 2011 |
Choschzick M, Oosterwijk E, Müller V, Woelber L, Simon R, Moch H, Tennstedt P. Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer. Virchows Archiv : An International Journal of Pathology. 459: 193-200. PMID 21691815 DOI: 10.1007/s00428-011-1105-y |
0.01 |
|
| 2011 |
Hudlebusch HR, Skotte J, Santoni-Rugiu E, Zimling ZG, Lees MJ, Simon R, Sauter G, Rota R, De Ioris MA, Quarto M, Johansen JV, Jørgensen M, Rechnitzer C, Maroun LL, Schrøder H, et al. MMSET is highly expressed and associated with aggressiveness in neuroblastoma. Cancer Research. 71: 4226-35. PMID 21527557 DOI: 10.1158/0008-5472.CAN-10-3810 |
0.01 |
|
| 2011 |
Chang J, Simon RA, Stevenson DD. Aspirin-exacerbated respiratory disease: is it in our DNA? Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 106: 263-4. PMID 21457872 DOI: 10.1016/j.anai.2010.12.016 |
0.01 |
|
| 2011 |
Weeks JA, Harper RA, Simon RA, Burdick JD. Assessment of sensitization risk of a laundry pre-spotter containing protease. Cutaneous and Ocular Toxicology. 30: 272-9. PMID 21434762 DOI: 10.3109/15569527.2011.565010 |
0.01 |
|
| 2011 |
Hudlebusch HR, Santoni-Rugiu E, Simon R, Ralfkiær E, Rossing HH, Johansen JV, Jørgensen M, Sauter G, Helin K. The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 2919-33. PMID 21385930 DOI: 10.1158/1078-0432.CCR-10-1302 |
0.01 |
|
| 2011 |
Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfield L, ... ... Simon RA, et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. Nutrition Research (New York, N.Y.). 31: 61-75. PMID 21310308 DOI: 10.1016/j.nutres.2011.01.001 |
0.01 |
|
| 2011 |
Boyce JA, Assa'a A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfield L, ... ... Simon RA, et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report. Nutrition (Burbank, Los Angeles County, Calif.). 27: 253-67. PMID 21215925 DOI: 10.1016/j.nut.2010.12.001 |
0.01 |
|
| 2011 |
Hu-Lowe DD, Chen E, Zhang L, Watson KD, Mancuso P, Lappin P, Wickman G, Chen JH, Wang J, Jiang X, Amundson K, Simon R, Erbersdobler A, Bergqvist S, Feng Z, et al. Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies. Cancer Research. 71: 1362-73. PMID 21212415 DOI: 10.1158/0008-5472.Can-10-1451 |
0.01 |
|
| 2011 |
Laack E, Simon R, Regier M, Andritzky B, Tennstedt P, Habermann C, Verth CZ, Thöm I, Grob T, Sauter G, Bokemeyer C. Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 199-202. PMID 21178715 DOI: 10.1097/JTO.0b013e3181fb7cf1 |
0.01 |
|
| 2011 |
Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfield L, ... ... Simon RA, et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel report. Journal of the American Academy of Dermatology. 64: 175-92. PMID 21167411 DOI: 10.1016/j.jaad.2010.11.020 |
0.01 |
|
| 2011 |
Rawnaq T, Kunkel M, Bachmann K, Simon R, Zander H, Brandl S, Sauter G, Izbicki JR, Kaifi JT. Serum midkine correlates with tumor progression and imatinib response in gastrointestinal stromal tumors Annals of Surgical Oncology. 18: 559-565. PMID 20589434 DOI: 10.1245/s10434-010-1191-0 |
0.01 |
|
| 2010 |
Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, ... ... Simon RA, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. The Journal of Allergy and Clinical Immunology. 126: S1-58. PMID 21134576 DOI: 10.1016/j.jaci.2010.10.007 |
0.01 |
|
| 2010 |
Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfield L, ... ... Simon RA, et al. Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. The Journal of Allergy and Clinical Immunology. 126: 1105-18. PMID 21134568 DOI: 10.1016/j.jaci.2010.10.008 |
0.01 |
|
| 2010 |
Stein T, Cosimo E, Yu X, Smith PR, Simon R, Cottrell L, Pringle MA, Bell AK, Lattanzio L, Sauter G, Lo Nigro C, Crook T, Machesky LM, Gusterson BA. Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis. The American Journal of Pathology. 177: 2323-33. PMID 20847288 DOI: 10.2353/ajpath.2010.100209 |
0.01 |
|
| 2010 |
Marx AH, Zielinski M, Kowitz CM, Dancau AM, Thieltges S, Simon R, Choschzick M, Yekebas E, Kaifi JT, Mirlacher M, Atanackovic D, Brümmendorf TH, Fiedler W, Bokemeyer C, Izbicki JR, et al. Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis. Histopathology. 57: 418-26. PMID 20840671 DOI: 10.1111/j.1365-2559.2010.03643.x |
0.01 |
|
| 2010 |
Minner S, Wittmer C, Graefen M, Salomon G, Steuber T, Haese A, Huland H, Bokemeyer C, Yekebas E, Dierlamm J, Balabanov S, Kilic E, Wilczak W, Simon R, Sauter G, et al. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer. The Prostate. 71: 281-8. PMID 20809553 DOI: 10.1002/pros.21241 |
0.01 |
|
| Hide low-probability matches. |